Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-106b-5p AKT3 2.81 0 -3.33 1.0E-5 miRNATAP -0.41 1.0E-5 NA
2 hsa-miR-142-3p AKT3 4.35 0 -3.33 1.0E-5 miRanda -0.16 0.00934 NA
3 hsa-miR-15a-5p AKT3 2.05 0 -3.33 1.0E-5 miRNAWalker2 validate; miRTarBase; miRNATAP -0.37 0.00021 NA
4 hsa-miR-15b-5p AKT3 3.32 0 -3.33 1.0E-5 miRNATAP -0.25 0.00571 NA
5 hsa-miR-16-5p AKT3 2.94 0 -3.33 1.0E-5 miRNAWalker2 validate; miRTarBase; miRNATAP -0.31 0.00086 NA
6 hsa-miR-29b-3p AKT3 0.67 0.23406 -3.33 1.0E-5 miRNATAP -0.28 0.00031 26512921 MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3
7 hsa-miR-3065-5p AKT3 2.14 0.06094 -3.33 1.0E-5 mirMAP -0.22 0 NA
8 hsa-miR-362-3p AKT3 0.68 0.22615 -3.33 1.0E-5 miRanda -0.25 0.00124 NA
9 hsa-miR-501-3p AKT3 1.72 0.00759 -3.33 1.0E-5 miRNATAP -0.18 0.00733 NA
10 hsa-miR-93-5p AKT3 2.66 0 -3.33 1.0E-5 miRNATAP -0.33 0.00021 NA
11 hsa-miR-3065-5p ANGPT1 2.14 0.06094 -3.47 0.00041 mirMAP -0.19 0.00141 NA
12 hsa-miR-429 ANGPT1 6.4 0 -3.47 0.00041 miRanda -0.28 0.00011 NA
13 hsa-miR-142-5p ANGPT2 3.96 0 -1.02 0.17676 MirTarget -0.17 0.00375 NA
14 hsa-miR-34c-5p ANGPT2 2.65 0.01574 -1.02 0.17676 miRanda -0.1 0.00939 NA
15 hsa-miR-429 ANGPT2 6.4 0 -1.02 0.17676 miRanda -0.16 0.00407 NA
16 hsa-miR-664a-3p ANGPT2 0.25 0.56171 -1.02 0.17676 mirMAP -0.29 0.00448 NA
17 hsa-miR-221-3p ATF2 0.94 0.17475 0.26 0.63833 MirTarget -0.17 0.00016 NA
18 hsa-miR-222-3p ATF2 1.55 0.0223 0.26 0.63833 MirTarget -0.17 0.00015 NA
19 hsa-miR-26a-5p ATF2 -0.35 0.36204 0.26 0.63833 MirTarget; miRNATAP -0.22 0.0074 NA
20 hsa-miR-29a-5p ATF2 0.07 0.88413 0.26 0.63833 MirTarget; miRNATAP -0.21 0.00035 NA
21 hsa-miR-30e-5p ATF2 0.78 0.03467 0.26 0.63833 mirMAP -0.26 0.00214 NA
22 hsa-miR-590-3p ATF2 2.35 0 0.26 0.63833 MirTarget; miRanda; mirMAP; miRNATAP -0.23 0.00018 NA
23 hsa-miR-320a ATF6B -0.91 0.05656 0.37 0.24574 miRanda -0.1 0.00628 NA
24 hsa-miR-16-2-3p BCL2 3.8 0 -3.06 1.0E-5 mirMAP -0.2 0.00813 NA
25 hsa-miR-16-5p BCL2 2.94 0 -3.06 1.0E-5 miRNAWalker2 validate; miRTarBase -0.27 0.00125 21336967; 24447552; 18449891; 25435430; 24598659; 18931683; 22966344; 25623762 P glycoprotein enhances radiation induced apoptotic cell death through the regulation of miR 16 and Bcl 2 expressions in hepatocellular carcinoma cells; RHepG2 cells the multidrug resistant subline of human hepatocellular carcinoma HepG2 cells expressed higher levels of Pgp as well as miR-16 and lower level of Bcl-2 than the parental cells; On the other hand ectopic mdr1 expression enhanced radiation-induced apoptosis in HepG2 cells SK-HEP-1 cells MiHa cells and furthermore induced miR-16 and suppressed its target gene Bcl-2 in HepG2 cells; Moreover the enhancement effects of Pgp and miR-16 on radiation-induced apoptosis were counteracted by overexpression of Bcl-2;To study the expression of miR-16 and bcl-2 in T lymphoblastic lymphoma/leukemia T-LBL/ALL and its relationship to prognosis; The relationship of miR-16 and bcl-2 was significantP = 0.042χ2 = 4.147; The relationship of miR-16 and bcl-2 might suggested that gene regulation may be influenced by them;miR 15b and miR 16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells; The downregulation of miR-15b and miR-16 in SGC7901/VCR cells was concurrent with the upregulation of Bcl-2 protein; Taken together our findings suggest that miR-15b and miR-16 could play a role in the development of MDR in gastric cancer cells at least in part by modulation of apoptosis via targeting BCL2;We demonstrated that anti-apoptotic protein Bcl-2 was directly targeted miR-16 in paclitaxel resistant lung cancer cells; Combined overexpression of miR-16 and miR-17 greatly reduced Beclin-1 and Bcl-2 expressions respectively; miR-17 overexpression reduced cytoprotective autophagy by targeting Beclin-1 whereas overexpression of miR-16 potentiated paclitaxel induced apoptotic cell death by inhibiting anti-apoptotic protein Bcl-2;The miR-16 expression correlated with BCL-2 protein r = 0.51 P < 0.05;MicroRNAs miRNAs are noncoding small RNAs that repress protein translation by targeting specific messenger RNAs miR-15a and miR-16-1 act as putative tumor suppressors by targeting the oncogene BCL2;The overall objective of our investigation was to assess whether miRNA-16 miR-16 is involved in the regulation of critical genes such as BCL2 that control the sensitivity of pancreatic cancer cells to apoptosis; This study showed that the ectopic overexpression of miR-16 may be therapeutically beneficial as is evidenced by impaired cell survival with concomitant attenuation of anti-apoptotic protein Bcl-2; Moreover the luciferase reporter assay suggested that miR-16 post-transcriptionally regulates Bcl-2 expression in pancreatic cancer cells through the target sites of the 3' untranslated region of this gene;miR 15a and miR 16 modulate drug resistance by targeting bcl 2 in human colon cancer cells; To investigate the reversal effect of targeted modulation of bcl-2 expression by miR-15a and miR-16 on drug resistance of human colon cancer cells
26 hsa-miR-192-5p BCL2 1.78 0.11349 -3.06 1.0E-5 miRNAWalker2 validate -0.13 0.00025 26550150 MicroRNA 192 regulates chemo resistance of lung adenocarcinoma for gemcitabine and cisplatin combined therapy by targeting Bcl 2; In this paper we try to test whether miR-192 regulates chemo-resistance in human carcinoma A549 mice model by targeting Bcl-2; MTT assay real-time RT-PCR western blotting assay were used to investigate miR-192 expression levels cell viability ratio and Bcl-2 protein expression levels; Bcl-2 mRNA and protein expression levels up-regulated in miR-192 inhibitor treated tumor; Bcl-2 is a key regulator for miR-192 related chemotherapy resistance; In this study we demonstrate that miR-192 regulates chemoresistance for gemcitabine and cisplatin combined chemotherapy in human adenocarcinoma lung cancer A549 cells and Bcl-2 is the target of miR-192
27 hsa-miR-200a-5p BCL2 6.52 0 -3.06 1.0E-5 mirMAP -0.2 0.00037 NA
28 hsa-miR-200b-5p BCL2 6.82 0 -3.06 1.0E-5 mirMAP -0.2 0.00019 NA
29 hsa-miR-200c-3p BCL2 6.47 0 -3.06 1.0E-5 miRNAWalker2 validate; miRTarBase; mirMAP -0.2 0.00073 NA
30 hsa-miR-21-5p BCL2 2.65 0 -3.06 1.0E-5 miRNAWalker2 validate; miRTarBase -0.48 4.0E-5 21468550; 25994220; 25381586; 26555418; 23359184; 22964582; 21376256 BCL-2 up-regulation could be achieved by miR-21 overexpression which prevented T24 cells from apoptosis induced by doxorubicin; Furthermore the miR-21 induced BCL-2 up-regulation could be cancelled by the PI3K inhibitor LY294002;Meanwhile miR-21 loss reduced STAT3 and Bcl-2 activation causing an increase in the apoptosis of tumour cells in CAC mice;Changes in the sensitivity of osteosarcoma cells to CDDP were examined after transfection with miR-21 mimics or anti-miR-21 or bcl-2 siRNA in combination with CDDP;The expression of Bax Bcl-2 and miR-21 in parental and paclitaxel-resistant cells was detected by RT-PCR and Western blotting;Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR 21 regulation of BCL 2 expression; We also used Western blot to measure BCL-2 protein levels after down-regulation of miR-21 expression; Besides down-regulation of miR-21 expression can inhibit BCL-2 expression in PANC-1 CFPAC-1 and MIA Paca-2 cells; Over-expression of miR-21 expression can reverse down-regulation of BCL-2 expression and apoptosis induced by resveratrol; In this study we demonstrated that the effect of resveratrol on apoptosis is due to inhibiting miR-21 regulation of BCL-2 expression;Tumors harvested from these lungs have elevated levels of oncogenic miRNAs miR-21 and miR-155; are deficient for p53-regulated miRNAs; and have heightened expression of miR-34 target genes such as Met and Bcl-2;Bcl 2 upregulation induced by miR 21 via a direct interaction is associated with apoptosis and chemoresistance in MIA PaCa 2 pancreatic cancer cells; However the roles and mechanisms of miRNA miR-21 in regulation of Bcl-2 in pancreatic cancer remain to be elucidated; Then luciferase activity was observed after miR-21 mimics and pRL-TK plasmids containing wild-type and mutant 3'UTRs of Bcl-2 mRNA were co-transfected; Cells transfected with miR-21 inhibitor revealed an opposite trend. There was a significant increase in luciferase activity in the cells transfected with the wild-type pRL-TK plasmid in contrast to those transfected with the mutant one indicating that miR-21 promotes Bcl-2 expression by binding directly to the 3'UTR of Bcl-2 mRNA; Upregulation of Bcl-2 directly induced by miR-21 is associated with apoptosis chemoresistance and proliferation of MIA PaCa-2 pancreatic cancer cells
31 hsa-miR-215-5p BCL2 3.67 0.00295 -3.06 1.0E-5 miRNAWalker2 validate -0.14 1.0E-5 NA
32 hsa-miR-24-2-5p BCL2 2.07 6.0E-5 -3.06 1.0E-5 miRNAWalker2 validate; miRTarBase -0.36 0 NA
33 hsa-miR-3065-5p BCL2 2.14 0.06094 -3.06 1.0E-5 mirMAP -0.17 0.00011 NA
34 hsa-miR-338-5p BCL2 -0.11 0.89468 -3.06 1.0E-5 PITA -0.15 0.00173 NA
35 hsa-miR-33b-5p BCL2 4.78 0 -3.06 1.0E-5 miRTarBase; mirMAP -0.12 0.00899 NA
36 hsa-miR-365a-3p BCL2 0.26 0.65432 -3.06 1.0E-5 miRNAWalker2 validate; miRTarBase -0.39 0 NA
37 hsa-miR-429 BCL2 6.4 0 -3.06 1.0E-5 miRNAWalker2 validate; miRTarBase; PITA; mirMAP -0.16 0.00181 23999873; 26513239; 26511969 MiR 429 up regulation induces apoptosis and suppresses invasion by targeting Bcl 2 and SP 1 in esophageal carcinoma; Subsequent Western blotting and luciferase reporter assays showed that miR-429 can bind to putative binding sites within the Bcl-2 and SP1 mRNA 3' untranslated regions UTRs to reduce their expression; Up-regulation of miR-429 inhibits invasion and promotes apoptosis in EC cells by targeting Bcl-2 and SP1; Our findings suggest that Bcl-2 and SP1 may serve as major targets of miR-429;MiR 429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl 2; Here we studied the levels of miR-429 and anti-apoptotic protein Bcl-2 in GC specimens; We performed bioinformatics analyses and used luciferase-reporter assay to analyze the relationship between miR-429 and Bcl-2 in GC cells; MiR-429 levels were significantly decreased and Bcl-2 levels were significantly increased in GC specimens compared to the paired adjacent non-tumor gastric tissue; Moreover the levels of miR-429 and Bcl-2 inversely correlated in GC specimens; Bioinformatics analyses showed that miR-429 targeted the 3'-UTR of Bcl-2 mRNA to inhibit its translation which was confirmed by luciferase-reporter assay;MiR 429 induces apoptosis of glioblastoma cell through Bcl 2; Here we analyzed the levels of miR-429 and anti-apoptotic protein Bcl-2 in GBM specimens; We combined bioinformatics analyses and luciferase reporter assay to determine the relationship between miR-429 and Bcl-2 in GBM cells; We found that miR-429 levels were significantly decreased and Bcl-2 levels were significantly increased in GBM specimens compared to the paired adjacent non-tumor brain tissue; Moreover the levels of miR-429 and Bcl-2 inversely correlated; MiR-429 targeted the 3'-UTR of Bcl-2 mRNA to inhibit its translation
38 hsa-miR-582-5p BCL2 0.69 0.44776 -3.06 1.0E-5 PITA -0.13 0.00231 NA
39 hsa-miR-629-5p BCL2 1.57 0.01157 -3.06 1.0E-5 mirMAP -0.25 7.0E-5 NA
40 hsa-miR-7-5p BCL2 3.6 0.00068 -3.06 1.0E-5 miRNAWalker2 validate; miRTarBase; mirMAP -0.12 0.00725 26464649; 25862909; 21750649 Western blotting was used to evaluate the effect of miR-7 on Bcl2 in A549 and H460 cells; Moreover subsequent experiments showed that BCL-2 was downregulated by miR-7 at both transcriptional and translational levels; This study further extends the biological role of miR-7 in NSCLC A549 and H460 cells and identifies BCL-2 as a novel target possibly involved in miR-7-mediated growth suppression and apoptosis induction of NSCLC cells;miR-7 overexpression correlated with diminished BCL2 expression but there was no relationship between miR-7 and EGFR expression neither in tumour samples nor in the cell lines; Of the two postulated miR-7 target genes we examined BCL2 but not EGFR seems to be a possible miR-7 target in OC;Bioinformatics predictions revealed a potential binding site of miR-7 on 3'UTR of BCL-2 and it was further confirmed by luciferase assay; Moreover subsequent experiments showed that BCL-2 was downregulated by miR-7 at both transcriptional and translational levels; These results suggest that miR-7 regulates the expression of BCL-2 through direct 3'UTR interactions
41 hsa-miR-342-3p BCL2L1 1.31 0.02072 0.39 0.37256 PITA; miRanda; miRNATAP -0.13 0.00344 NA
42 hsa-miR-30a-5p BCL2L11 -0.77 0.32049 1.51 0.0002 miRNATAP -0.12 4.0E-5 NA
43 hsa-miR-1-3p BDNF -3.85 1.0E-5 1.93 0.15403 miRTarBase; MirTarget -0.24 0.007 NA
44 hsa-miR-146b-5p BDNF 1.88 0.00074 1.93 0.15403 miRanda -0.4 0.00389 NA
45 hsa-let-7a-5p CCND1 0.15 0.64531 0.15 0.87753 TargetScan; miRNATAP -0.54 0.00245 NA
46 hsa-miR-106a-5p CCND1 3.99 0 0.15 0.87753 MirTarget; miRNATAP -0.43 0 NA
47 hsa-miR-15a-5p CCND1 2.05 0 0.15 0.87753 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.35 0.00776 22922827 CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR
48 hsa-miR-15b-5p CCND1 3.32 0 0.15 0.87753 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.42 0.00029 NA
49 hsa-miR-20b-5p CCND1 4.57 5.0E-5 0.15 0.87753 MirTarget; miRNATAP -0.31 0 NA
50 hsa-miR-34a-5p CCND1 0.83 0.04775 0.15 0.87753 miRNAWalker2 validate; miRTarBase; miRNATAP -0.42 0.00174 25792709; 21399894 This inhibition of proliferation was associated with a decrease in cyclin D1 levels orchestrated principally by HNF-4α a target of miR-34a considered to act as a tumour suppressor in the liver;Quantitative PCR and western analysis confirmed decreased expression of two genes BCL-2 and CCND1 in docetaxel-resistant cells which are both targeted by miR-34a
51 hsa-miR-497-5p CCND1 -1.44 0.02251 0.15 0.87753 MirTarget; miRNATAP -0.25 0.00498 21350001 Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497 miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer
52 hsa-miR-106a-5p CCND2 3.99 0 -2.81 0.0014 miRNATAP -0.44 0 NA
53 hsa-miR-106b-5p CCND2 2.81 0 -2.81 0.0014 miRNAWalker2 validate; miRTarBase; miRNATAP -0.31 0.00374 NA
54 hsa-miR-10a-3p CCND2 0.97 0.31667 -2.81 0.0014 mirMAP -0.2 0.00011 NA
55 hsa-miR-130b-5p CCND2 3.74 0 -2.81 0.0014 mirMAP -0.46 0 NA
56 hsa-miR-141-3p CCND2 7.3 0 -2.81 0.0014 MirTarget; TargetScan -0.24 0.00021 NA
57 hsa-miR-15b-5p CCND2 3.32 0 -2.81 0.0014 miRNATAP -0.53 0 NA
58 hsa-miR-16-2-3p CCND2 3.8 0 -2.81 0.0014 mirMAP -0.29 0.00207 NA
59 hsa-miR-182-5p CCND2 5.87 0 -2.81 0.0014 miRNAWalker2 validate; miRTarBase; miRNATAP -0.28 2.0E-5 NA
60 hsa-miR-183-5p CCND2 6.62 0 -2.81 0.0014 miRNATAP -0.29 0 NA
61 hsa-miR-191-5p CCND2 1.59 0.00074 -2.81 0.0014 MirTarget -0.32 0.00314 NA
62 hsa-miR-200a-3p CCND2 6.34 0 -2.81 0.0014 MirTarget -0.41 0 NA
63 hsa-miR-20b-5p CCND2 4.57 5.0E-5 -2.81 0.0014 miRNATAP -0.3 0 NA
64 hsa-miR-224-3p CCND2 2.85 0.00018 -2.81 0.0014 mirMAP -0.22 0.00101 NA
65 hsa-miR-28-5p CCND2 -0.82 0.02212 -2.81 0.0014 miRanda -0.43 0.00273 NA
66 hsa-miR-3065-3p CCND2 1.89 0.03082 -2.81 0.0014 MirTarget; miRNATAP -0.21 0.00027 NA
67 hsa-miR-3065-5p CCND2 2.14 0.06094 -2.81 0.0014 mirMAP -0.2 0.00026 NA
68 hsa-miR-30d-3p CCND2 -0.07 0.85742 -2.81 0.0014 mirMAP -0.55 1.0E-5 NA
69 hsa-miR-324-3p CCND2 1.51 0.00384 -2.81 0.0014 miRNAWalker2 validate -0.44 0 NA
70 hsa-miR-33a-3p CCND2 2.06 0.00156 -2.81 0.0014 MirTarget -0.27 0.00041 NA
71 hsa-miR-378a-3p CCND2 1.47 0.04667 -2.81 0.0014 miRNAWalker2 validate -0.19 0.00601 NA
72 hsa-miR-429 CCND2 6.4 0 -2.81 0.0014 miRNATAP -0.46 0 NA
73 hsa-miR-497-5p CCND2 -1.44 0.02251 -2.81 0.0014 MirTarget; miRNATAP -0.27 0.00058 NA
74 hsa-miR-550a-5p CCND2 1.22 0.06138 -2.81 0.0014 MirTarget -0.22 0.00363 NA
75 hsa-miR-660-5p CCND2 -0.07 0.88525 -2.81 0.0014 mirMAP -0.29 0.00793 NA
76 hsa-miR-9-3p CCND2 1.69 0.12517 -2.81 0.0014 MirTarget; mirMAP; miRNATAP -0.14 0.00185 NA
77 hsa-miR-93-5p CCND2 2.66 0 -2.81 0.0014 miRNATAP -0.48 0 NA
78 hsa-miR-96-5p CCND2 5.63 0 -2.81 0.0014 TargetScan; miRNATAP -0.24 0.0003 NA
79 hsa-miR-27b-3p CCND3 -0.09 0.85847 -0.54 0.12437 miRNAWalker2 validate -0.14 0.00019 NA
80 hsa-miR-429 CCND3 6.4 0 -0.54 0.12437 miRNATAP -0.11 1.0E-5 NA
81 hsa-miR-96-5p CCND3 5.63 0 -0.54 0.12437 TargetScan -0.12 1.0E-5 NA
82 hsa-miR-125b-5p CCNE1 -2.01 0.00516 3.91 0 miRNAWalker2 validate -0.13 0.00065 NA
83 hsa-miR-195-5p CCNE1 -1.59 0.01691 3.91 0 miRNAWalker2 validate; MirTarget; miRNATAP -0.12 0.0047 24402230 Furthermore through qPCR and western blot assays we showed that overexpression of miR-195-5p reduced CCNE1 mRNA and protein levels respectively
84 hsa-miR-26a-5p CCNE1 -0.35 0.36204 3.91 0 miRNAWalker2 validate; miRTarBase; miRNATAP -0.18 0.00988 22094936 Cell cycle regulation and CCNE1 and CDC2 were the only significant overlapping pathway and genes differentially expressed between tumors with high and low levels of miR-26a and EZH2 respectively; Low mRNA levels of EZH2 CCNE1 and CDC2 and high levels of miR-26a are associated with favorable outcome on tamoxifen
85 hsa-miR-497-5p CCNE1 -1.44 0.02251 3.91 0 MirTarget; miRNATAP -0.13 0.00315 24909281; 24112607; 25909221 miR 497 suppresses proliferation of human cervical carcinoma HeLa cells by targeting cyclin E1; Furthermore the target effect of miR-497 on the CCNE1 was identified by dual-luciferase reporter assay system qRT-PCR and Western blotting; Over-expressed miR-497 in HeLa cells could suppress cell proliferation by targeting CCNE1;Western blot assays confirmed that overexpression of miR-497 reduced cyclin E1 protein levels; Inhibited cellular growth suppressed cellular migration and invasion and G1 cell cycle arrest were observed upon overexpression of miR-497 in cells possibly by targeting cyclin E1;The effect of simultaneous overexpression of miR-497 and miR-34a on the inhibition of cell proliferation colony formation and tumor growth and the downregulation of cyclin E1 was stronger than the effect of each miRNA alone; The synergistic actions of miR-497 and miR-34a partly correlated with cyclin E1 levels; These results indicate cyclin E1 is downregulated by both miR-497 and miR-34a which synergistically retard the growth of human lung cancer cells
86 hsa-miR-28-3p CCNE2 -0.99 0.01882 4.78 0 PITA; miRNATAP -0.21 0.00739 NA
87 hsa-miR-30a-5p CCNE2 -0.77 0.32049 4.78 0 miRNATAP -0.23 0 NA
88 hsa-miR-140-5p CDK2 -0.63 0.12667 1.42 2.0E-5 miRanda -0.12 0.00814 NA
89 hsa-let-7a-5p CDK6 0.15 0.64531 0.5 0.55124 miRNAWalker2 validate; miRTarBase; TargetScan -0.65 2.0E-5 NA
90 hsa-let-7b-5p CDK6 -0.19 0.65188 0.5 0.55124 miRNAWalker2 validate; miRTarBase -0.47 5.0E-5 NA
91 hsa-miR-101-3p CDK6 -1.12 0.02009 0.5 0.55124 mirMAP -0.42 2.0E-5 NA
92 hsa-miR-106a-5p CDK6 3.99 0 0.5 0.55124 mirMAP -0.39 0 NA
93 hsa-miR-141-3p CDK6 7.3 0 0.5 0.55124 TargetScan; miRNATAP -0.2 0.0009 NA
94 hsa-miR-148b-3p CDK6 1.76 0 0.5 0.55124 mirMAP -0.47 0.00118 NA
95 hsa-miR-200a-3p CDK6 6.34 0 0.5 0.55124 miRNATAP -0.35 0 24009066 microRNA 200a is an independent prognostic factor of hepatocellular carcinoma and induces cell cycle arrest by targeting CDK6
96 hsa-miR-200b-3p CDK6 5.56 0 0.5 0.55124 mirMAP -0.39 0 NA
97 hsa-miR-20b-5p CDK6 4.57 5.0E-5 0.5 0.55124 mirMAP -0.28 0 26166554 The transfection of miR-20b into EJ cells induced G1 phase cell cycle arrest via the decreased expression of cyclin D1 CDK2 and CDK6 without affecting another G1 phase cell cycle regulator cyclin E
98 hsa-miR-30a-5p CDK6 -0.77 0.32049 0.5 0.55124 mirMAP -0.17 0.00517 NA
99 hsa-miR-30d-5p CDK6 0.3 0.38019 0.5 0.55124 mirMAP -0.5 0.00043 NA
100 hsa-miR-30e-5p CDK6 0.78 0.03467 0.5 0.55124 mirMAP -0.54 4.0E-5 NA
101 hsa-miR-34a-5p CDK6 0.83 0.04775 0.5 0.55124 miRNAWalker2 validate; miRTarBase; miRNATAP -0.36 0.00175 21702042; 26104764 Molecular analyses identified Cdk6 and sirtuin SIRT-1 as being targeted by miR-34a in MI-TCC cells however inhibition of Cdk6 and SIRT-1 was not as effective as pre-miR-34a in mediating chemosensitization;The expression of microRNA 34a is inversely correlated with c MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients; We found significant inverse correlations between miR-34a and c-MET R = -0.316 P = 0.028 and CDK6 expression R = -0.4582 P = 0.004
102 hsa-miR-362-5p CDK6 -1.22 0.04527 0.5 0.55124 mirMAP -0.29 0.00026 NA
103 hsa-miR-429 CDK6 6.4 0 0.5 0.55124 mirMAP; miRNATAP -0.25 4.0E-5 NA
104 hsa-miR-497-5p CDK6 -1.44 0.02251 0.5 0.55124 miRNATAP -0.31 3.0E-5 NA
105 hsa-miR-502-3p CDK6 -0.1 0.80889 0.5 0.55124 PITA; miRNATAP -0.42 0.00027 NA
106 hsa-miR-592 CDK6 2.8 0.02935 0.5 0.55124 mirMAP -0.23 0 NA
107 hsa-miR-660-5p CDK6 -0.07 0.88525 0.5 0.55124 mirMAP -0.37 0.00036 NA
108 hsa-let-7e-5p CDKN1A -0.11 0.81474 0.58 0.35758 MirTarget -0.27 0.00026 NA
109 hsa-let-7g-5p CDKN1A 0.86 0.00648 0.58 0.35758 MirTarget -0.32 0.00586 NA
110 hsa-miR-125a-5p CDKN1A -1.32 0.00714 0.58 0.35758 miRNAWalker2 validate; miRTarBase -0.35 0 NA
111 hsa-miR-28-5p CDKN1A -0.82 0.02212 0.58 0.35758 miRNAWalker2 validate; miRTarBase; MirTarget; miRanda; miRNATAP -0.55 0 NA
112 hsa-miR-30b-3p CDKN1A 0.17 0.76608 0.58 0.35758 MirTarget -0.16 0.00864 NA
113 hsa-miR-335-5p CDKN1A 0.17 0.8039 0.58 0.35758 miRNAWalker2 validate -0.25 0 NA
114 hsa-miR-345-5p CDKN1A 2.77 4.0E-5 0.58 0.35758 miRNAWalker2 validate; miRTarBase; MirTarget -0.23 1.0E-5 NA
115 hsa-miR-423-3p CDKN1A 1.71 2.0E-5 0.58 0.35758 miRNAWalker2 validate; miRTarBase -0.27 0.00253 NA
116 hsa-miR-505-5p CDKN1A -0.55 0.33141 0.58 0.35758 miRNAWalker2 validate; MirTarget -0.18 0.00519 NA
117 hsa-miR-616-5p CDKN1A 2.48 0.00318 0.58 0.35758 mirMAP -0.14 0.0061 NA
118 hsa-miR-96-5p CDKN1A 5.63 0 0.58 0.35758 miRNAWalker2 validate; miRTarBase -0.17 0.00034 26582573 Upregulation of microRNA 96 and its oncogenic functions by targeting CDKN1A in bladder cancer; Bioinformatics prediction combined with luciferase reporter assay were used to verify whether the cyclin-dependent kinase inhibitor CDKN1A was a potential target gene of miR-96; According to the data of miRTarBase CDKN1A might be a candidate target gene of miR-96; In addition luciferase reporter and Western blot assays respectively demonstrated that miR-96 could bind to the putative seed region in CDKN1A mRNA 3'UTR and significantly reduce the expression level of CDKN1A protein; Moreover we found that the inhibition of miR-96 expression remarkably decreased cell proliferation and promoted cell apoptosis of BC cell lines which was consistent with the findings observed following the introduction of CDKN1A cDNA without 3'UTR restored miR-96; Upregulation of miR-96 may contribute to aggressive malignancy partly through suppressing CDKN1A protein expression in BC cells
119 hsa-miR-221-3p CDKN1B 0.94 0.17475 -0.76 0.02874 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.2 0 23637992; 19953484; 23939688; 19126397; 20146005; 23967190; 17569667; 22992757; 17721077; 20461750 miR-221 knockdown not only blocked cell cycle progression induced cell apoptosis and inhibited cell proliferation in-vitro but it also inhibited in-vivo tumor growth by targeting p27kip1;Based on bioinformatic analysis we found that the seed sequences of miR-221 and miR-222 coincide with each other and p27kip1 is a target for miRNA-221/222;A Slug/miR-221 network has been suggested linking miR-221 activity with the downregulation of a Slug repressor leading to Slug/miR-221 upregulation and p27Kip1 downregulation; Interference with this process can be achieved using antisense miRNA antagomiR molecules targeting miR-221 inducing the downregulation of Slug and the upregulation of p27Kip1;Moreover a series of functional assays demonstrated that mir-221 could directly inhibit cKit p27Kip1 and possibly other pivotal proteins in melanoma;Matched HCC and adjacent non-cancerous samples were assayed for the expression of miR-221 and three G1/S transition inhibitors: p27Kip1 p21WAF1/Cip1and TGF-β1 by in situ hybridization and immunohistochemistry respectively; Real time qRT-PCR was used to investigate miR-221 and p27Kip1 transcripts in different clinical stages; In result miR-221 and TGF-β1 are frequently up-regulated in HCC while p27Kip1 and p21WAF1/Cip1 proteins are frequently down-regulated; In conclusion miR-221 is important in tumorigenesis of HCC possibly by specifically down-regulating p27Kip1 a cell-cycle inhibitor;Additionally the PDGF-dependent increase in cell proliferation appears to be mediated by inhibition of a specific target of miR-221 and down-regulation of p27Kip1;miR 221 and miR 222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1; In all cell lines tested we show an inverse relationship between the expression of miR-221 and miR-222 and the cell cycle inhibitor p27Kip1; Consistently miR-221 and miR-222 knock-down through antisense LNA oligonucleotides increases p27Kip1 in PC3 cells and strongly reduces their clonogenicity in vitro;Peptide nucleic acids targeting miR 221 modulate p27Kip1 expression in breast cancer MDA MB 231 cells; Targeting miR-221 by PNA resulted in i lowering of the hybridization levels of miR-221 measured by RT-qPCR ii upregulation of p27Kip1 gene expression measured by RT-qPCR and western blot analysis;Antagonism of either microRNA 221 or 222 in glioblastoma cells also caused an increase in p27Kip1 levels and enhanced expression of the luciferase reporter gene fused to the p27Kip1 3'UTR;MiR 221 and MiR 222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B CDKNIC and overall survival; miR-221 and miR-222 negatively regulate expression of CDKN1B p27 and CDKN1C p57 two cell cycle regulators expressed in ovarian surface epithelium and down-regulated in ovarian carcinomas; In contrast CDKN1B expression was not associated with miR-221 or miR-222 expression
120 hsa-miR-222-3p CDKN1B 1.55 0.0223 -0.76 0.02874 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.2 0 24895988; 19953484; 26912358; 24137356; 17569667; 27282281; 20461750 MiR-222 plays an important role in the tumorigenesis of CC possibly by specifically down-regulating p27Kip1 and PTEN;Based on bioinformatic analysis we found that the seed sequences of miR-221 and miR-222 coincide with each other and p27kip1 is a target for miRNA-221/222;Besides microvesicle marker characterization we evidenced that miR-222 exosomal expression mostly reflected its abundance in the cells of origin correctly paralleled by repression of its target genes such as p27Kip1 and induction of the PI3K/AKT pathway thus confirming its functional implication in cancer;miR 222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27kip1; miR-222 upregulation induced an enhancement of ovarian cancer cell proliferation potential possibly by downregulating its target P27Kip1; A bioinformatic analysis showed that the 3'-UTR of the P27Kip1 mRNA contained a highly-conserved putative miR-222 binding site; Luciferase reporter assays demonstrated that P27Kip1 was a direct target of miR-222; Consistently there was an inverse correlation between the P27Kip1 and miR-222 expression levels in the ovarian cancer cell lines and tissues;miR 221 and miR 222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1; In all cell lines tested we show an inverse relationship between the expression of miR-221 and miR-222 and the cell cycle inhibitor p27Kip1; Consistently miR-221 and miR-222 knock-down through antisense LNA oligonucleotides increases p27Kip1 in PC3 cells and strongly reduces their clonogenicity in vitro;miR 222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27kip1 expression; Immunofluorescence showed that miR-222 altered the subcellular location of p27kip1 in nucleus; The results showed that downregulation of miR-222 in MCF-7/Adr increased sensitivity to Adr and Adr-induced apoptosis and arrested the cells in G1 phase accompanied by more expressions of p27kip1 especially in nucleus; Taken together the results found that miR-222 induced Adr-resistance at least in part via suppressing p27kip1 expression and altering its subcellular localization and miR-222 inhibitors could reverse Adr-resistance of breast cancer cells;MiR 221 and MiR 222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B CDKNIC and overall survival; miR-221 and miR-222 negatively regulate expression of CDKN1B p27 and CDKN1C p57 two cell cycle regulators expressed in ovarian surface epithelium and down-regulated in ovarian carcinomas; In contrast CDKN1B expression was not associated with miR-221 or miR-222 expression
121 hsa-miR-24-3p CDKN1B 1.56 0.00052 -0.76 0.02874 miRNAWalker2 validate; miRNATAP -0.23 0 26847530; 26044523 The biological significance of miR-24 expression in prostate cancer cells was assessed by a series of in vitro bioassays and the effect on proposed targets p27 CDKN1B and p16 CDK2NA was investigated;With the bioinformatic method we further identified that p27Kip1 is a direct target of miR-24-3p and its protein level was negatively regulated by miR-24-3p
122 hsa-miR-421 CDKN1B 1.98 0.00092 -0.76 0.02874 miRanda -0.11 0.0006 NA
123 hsa-miR-455-5p CDKN1B -0.32 0.6163 -0.76 0.02874 miRanda; miRNATAP -0.11 0.00022 NA
124 hsa-miR-221-5p CHAD 2.07 0.07573 -0.72 0.5484 MirTarget -0.29 0 NA
125 hsa-miR-222-5p CHAD 2.52 0.00142 -0.72 0.5484 MirTarget -0.35 5.0E-5 NA
126 hsa-miR-27a-3p CHRM1 1.76 0.00022 -0.18 0.90095 miRNATAP -0.83 0 NA
127 hsa-miR-342-3p CHRM1 1.31 0.02072 -0.18 0.90095 miRanda -0.43 0.00215 NA
128 hsa-let-7d-5p COL1A1 0.83 0.0127 -1.84 0.04283 miRNATAP -0.74 0 NA
129 hsa-let-7f-5p COL1A1 0.97 0.02403 -1.84 0.04283 miRNATAP -0.33 0.0062 NA
130 hsa-let-7g-5p COL1A1 0.86 0.00648 -1.84 0.04283 miRNATAP -0.78 0 NA
131 hsa-miR-106a-5p COL1A1 3.99 0 -1.84 0.04283 mirMAP -0.27 1.0E-5 NA
132 hsa-miR-106b-5p COL1A1 2.81 0 -1.84 0.04283 mirMAP -0.53 0 NA
133 hsa-miR-107 COL1A1 1.49 0.00013 -1.84 0.04283 PITA; miRanda -0.36 0.00642 NA
134 hsa-miR-17-5p COL1A1 2.33 2.0E-5 -1.84 0.04283 mirMAP -0.33 0.00039 NA
135 hsa-miR-196a-5p COL1A1 2.72 0.02338 -1.84 0.04283 miRNATAP -0.14 0.00102 NA
136 hsa-miR-20a-5p COL1A1 2.14 0.00018 -1.84 0.04283 mirMAP -0.31 0.00051 NA
137 hsa-miR-20b-5p COL1A1 4.57 5.0E-5 -1.84 0.04283 mirMAP -0.14 0.00174 NA
138 hsa-miR-23a-5p COL1A1 2.87 0.00029 -1.84 0.04283 mirMAP -0.17 0.00705 NA
139 hsa-miR-29c-3p COL1A1 -0.41 0.52934 -1.84 0.04283 miRNAWalker2 validate; miRTarBase; miRNATAP -0.25 0.00176 NA
140 hsa-miR-30d-3p COL1A1 -0.07 0.85742 -1.84 0.04283 mirMAP -0.51 6.0E-5 NA
141 hsa-miR-30e-3p COL1A1 -0.04 0.93258 -1.84 0.04283 mirMAP -0.48 8.0E-5 NA
142 hsa-miR-330-3p COL1A1 2.49 0.00013 -1.84 0.04283 mirMAP -0.27 0.00063 NA
143 hsa-miR-361-3p COL1A1 0.81 0.04185 -1.84 0.04283 PITA -0.55 2.0E-5 NA
144 hsa-miR-532-3p COL1A1 0.64 0.21484 -1.84 0.04283 PITA; miRNATAP -0.26 0.00868 NA
145 hsa-miR-590-3p COL1A1 2.35 0 -1.84 0.04283 miRanda -0.37 0.00025 NA
146 hsa-miR-616-5p COL1A1 2.48 0.00318 -1.84 0.04283 mirMAP; miRNATAP -0.2 0.00773 NA
147 hsa-miR-625-5p COL1A1 2.03 0.00094 -1.84 0.04283 MirTarget -0.26 0.00211 NA
148 hsa-miR-92a-1-5p COL1A1 2.15 0.00155 -1.84 0.04283 MirTarget -0.43 0 NA
149 hsa-miR-93-5p COL1A1 2.66 0 -1.84 0.04283 mirMAP -0.4 0.00014 NA
150 hsa-let-7d-5p COL1A2 0.83 0.0127 -2.41 0.0132 MirTarget; miRNATAP -0.81 0 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF PHOSPHORUS METABOLIC PROCESS 107 1618 2.077e-61 9.665e-58
2 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 67 498 4.294e-56 9.99e-53
3 REGULATION OF PROTEIN MODIFICATION PROCESS 103 1710 1.064e-54 1.65e-51
4 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 83 1036 3.736e-52 3.476e-49
5 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 83 1036 3.736e-52 3.476e-49
6 REGULATION OF KINASE ACTIVITY 74 776 2.473e-51 1.918e-48
7 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 70 689 3.231e-50 2.148e-47
8 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 100 1848 1.812e-48 1.054e-45
9 POSITIVE REGULATION OF CELL PROLIFERATION 72 814 1.543e-47 7.975e-45
10 POSITIVE REGULATION OF KINASE ACTIVITY 59 482 1.328e-46 6.078e-44
11 REGULATION OF CELL PROLIFERATION 90 1496 1.437e-46 6.078e-44
12 LOCOMOTION 80 1114 1.972e-46 7.646e-44
13 REGULATION OF TRANSFERASE ACTIVITY 75 946 2.833e-46 1.014e-43
14 POSITIVE REGULATION OF RESPONSE TO STIMULUS 99 1929 8.424e-46 2.613e-43
15 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 80 1135 8.072e-46 2.613e-43
16 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 89 1492 1.151e-45 3.349e-43
17 PROTEIN PHOSPHORYLATION 74 944 2.992e-45 8.188e-43
18 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 92 1656 7.664e-45 1.952e-42
19 POSITIVE REGULATION OF MOLECULAR FUNCTION 95 1791 7.969e-45 1.952e-42
20 REGULATION OF CELLULAR COMPONENT MOVEMENT 67 771 1.746e-43 4.063e-41
21 POSITIVE REGULATION OF LOCOMOTION 53 420 2.187e-42 4.845e-40
22 POSITIVE REGULATION OF CATALYTIC ACTIVITY 86 1518 3.999e-42 8.457e-40
23 POSITIVE REGULATION OF CELL COMMUNICATION 86 1532 8.229e-42 1.665e-39
24 EXTRACELLULAR STRUCTURE ORGANIZATION 47 304 1.08e-41 2.094e-39
25 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 60 616 1.539e-41 2.864e-39
26 CELL MOTILITY 67 835 2.907e-41 5.01e-39
27 LOCALIZATION OF CELL 67 835 2.907e-41 5.01e-39
28 POSITIVE REGULATION OF MAPK CASCADE 54 470 5.158e-41 8.571e-39
29 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 68 876 5.355e-41 8.592e-39
30 REGULATION OF MAPK CASCADE 61 660 6.41e-41 9.941e-39
31 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 88 1672 1.074e-40 1.613e-38
32 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 36 138 1.153e-40 1.677e-38
33 PHOSPHORYLATION 77 1228 2.905e-40 4.096e-38
34 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 78 1275 4.455e-40 6.097e-38
35 INTRACELLULAR SIGNAL TRANSDUCTION 85 1572 5.398e-40 7.176e-38
36 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 51 470 2.064e-37 2.668e-35
37 REGULATION OF CELL DEATH 79 1472 1.458e-36 1.834e-34
38 RESPONSE TO ENDOGENOUS STIMULUS 77 1450 3.322e-35 4.068e-33
39 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 41 289 9.563e-35 1.141e-32
40 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 75 1395 1.52e-34 1.768e-32
41 BIOLOGICAL ADHESION 66 1032 1.606e-34 1.823e-32
42 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 64 1008 3.263e-33 3.615e-31
43 NEGATIVE REGULATION OF CELL DEATH 60 872 6.237e-33 6.749e-31
44 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 67 1142 8.505e-33 8.994e-31
45 TISSUE DEVELOPMENT 75 1518 4.278e-32 4.424e-30
46 CELL SUBSTRATE ADHESION 32 164 8.883e-32 8.986e-30
47 RESPONSE TO EXTERNAL STIMULUS 81 1821 9.215e-32 9.123e-30
48 REGULATION OF MAP KINASE ACTIVITY 40 319 9.882e-32 9.579e-30
49 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 84 1977 1.137e-31 1.08e-29
50 RESPONSE TO GROWTH FACTOR 46 475 1.891e-31 1.759e-29
51 PEPTIDYL TYROSINE MODIFICATION 33 186 2.577e-31 2.306e-29
52 INOSITOL LIPID MEDIATED SIGNALING 29 124 2.558e-31 2.306e-29
53 POSITIVE REGULATION OF MAP KINASE ACTIVITY 34 207 4.605e-31 4.043e-29
54 VASCULATURE DEVELOPMENT 45 469 1.396e-30 1.203e-28
55 REGULATION OF CELL DIFFERENTIATION 70 1492 2.322e-28 1.964e-26
56 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 57 957 6.103e-28 5.071e-26
57 ACTIVATION OF PROTEIN KINASE ACTIVITY 35 279 8.528e-28 6.961e-26
58 TAXIS 42 464 1.661e-27 1.332e-25
59 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 58 1021 2.187e-27 1.725e-25
60 CELL MATRIX ADHESION 26 119 2.55e-27 1.978e-25
61 REGULATION OF CELL ADHESION 47 629 4.027e-27 3.071e-25
62 ANGIOGENESIS 35 293 4.694e-27 3.523e-25
63 RESPONSE TO HORMONE 54 893 9.996e-27 7.382e-25
64 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 39 404 1.371e-26 9.97e-25
65 CARDIOVASCULAR SYSTEM DEVELOPMENT 51 788 1.489e-26 1.049e-24
66 CIRCULATORY SYSTEM DEVELOPMENT 51 788 1.489e-26 1.049e-24
67 RESPONSE TO OXYGEN CONTAINING COMPOUND 65 1381 3.078e-26 2.137e-24
68 BLOOD VESSEL MORPHOGENESIS 37 364 4.88e-26 3.339e-24
69 REGULATION OF HYDROLASE ACTIVITY 63 1327 1.42e-25 9.573e-24
70 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 30 213 2.032e-25 1.351e-23
71 LEUKOCYTE MIGRATION 32 259 3.045e-25 1.995e-23
72 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 27 162 5.636e-25 3.642e-23
73 LIPID PHOSPHORYLATION 23 99 6.124e-25 3.904e-23
74 ORGAN MORPHOGENESIS 50 841 2.35e-24 1.478e-22
75 CELL DEVELOPMENT 63 1426 6.91e-24 4.287e-22
76 INTEGRIN MEDIATED SIGNALING PATHWAY 21 82 7.743e-24 4.741e-22
77 PEPTIDYL AMINO ACID MODIFICATION 49 841 1.792e-23 1.083e-21
78 RESPONSE TO NITROGEN COMPOUND 49 859 4.507e-23 2.689e-21
79 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 47 799 1.133e-22 6.672e-21
80 REGULATION OF IMMUNE SYSTEM PROCESS 60 1403 5.832e-22 3.392e-20
81 IMMUNE SYSTEM PROCESS 71 1984 8.761e-22 5.033e-20
82 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 18 62 1.088e-21 6.174e-20
83 REGULATION OF EPITHELIAL CELL PROLIFERATION 30 285 1.186e-21 6.65e-20
84 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 26 193 1.257e-21 6.962e-20
85 POSITIVE REGULATION OF CELL DIFFERENTIATION 46 823 2.798e-21 1.532e-19
86 CELLULAR RESPONSE TO NITROGEN COMPOUND 37 505 4.638e-21 2.509e-19
87 CELL DEATH 50 1001 4.982e-21 2.664e-19
88 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 53 1152 1.052e-20 5.562e-19
89 REGULATION OF VASCULATURE DEVELOPMENT 27 233 1.144e-20 5.978e-19
90 REGULATION OF LIPID KINASE ACTIVITY 16 48 1.625e-20 8.401e-19
91 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 16 49 2.391e-20 1.223e-18
92 CELL ACTIVATION 38 568 3.008e-20 1.521e-18
93 POSITIVE REGULATION OF CELL ADHESION 32 376 3.186e-20 1.594e-18
94 EMBRYO DEVELOPMENT 46 894 7.785e-20 3.854e-18
95 CELLULAR RESPONSE TO HORMONE STIMULUS 37 552 9.416e-20 4.612e-18
96 POSITIVE REGULATION OF HYDROLASE ACTIVITY 46 905 1.266e-19 6.138e-18
97 LIPID MODIFICATION 25 210 1.713e-19 8.216e-18
98 RESPONSE TO WOUNDING 37 563 1.824e-19 8.659e-18
99 RESPONSE TO PEPTIDE 32 404 2.743e-19 1.289e-17
100 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 22 154 5.139e-19 2.391e-17
101 POSITIVE REGULATION OF CHEMOTAXIS 20 120 9.355e-19 4.31e-17
102 REGULATION OF CHEMOTAXIS 23 180 1.031e-18 4.702e-17
103 CELL PROLIFERATION 39 672 1.289e-18 5.825e-17
104 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 14 40 1.902e-18 8.511e-17
105 NEUROGENESIS 55 1402 2.425e-18 1.074e-16
106 REGULATION OF EPITHELIAL CELL MIGRATION 22 166 2.711e-18 1.19e-16
107 WOUND HEALING 33 470 2.807e-18 1.22e-16
108 CELLULAR COMPONENT MORPHOGENESIS 44 900 3.946e-18 1.7e-16
109 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 34 513 4.855e-18 2.073e-16
110 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 43 867 5.982e-18 2.531e-16
111 POSITIVE REGULATION OF CELL DIVISION 20 132 6.637e-18 2.782e-16
112 REGULATION OF CELL SUBSTRATE ADHESION 22 173 6.719e-18 2.791e-16
113 REGULATION OF ENDOTHELIAL CELL MIGRATION 19 114 7.129e-18 2.935e-16
114 SINGLE ORGANISM CELL ADHESION 32 459 1.18e-17 4.818e-16
115 REGULATION OF NEURON DEATH 25 252 1.456e-17 5.889e-16
116 PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 19 120 1.947e-17 7.808e-16
117 PLATELET ACTIVATION 20 142 2.924e-17 1.163e-15
118 REGULATION OF ERK1 AND ERK2 CASCADE 24 238 4.596e-17 1.812e-15
119 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 26 296 6.426e-17 2.513e-15
120 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 26 297 6.98e-17 2.707e-15
121 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 52 1360 7.656e-17 2.944e-15
122 RESPONSE TO LIPID 42 888 8.459e-17 3.226e-15
123 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 21 172 9.138e-17 3.457e-15
124 CELLULAR RESPONSE TO PEPTIDE 25 274 1.075e-16 4.033e-15
125 REGULATION OF BODY FLUID LEVELS 32 506 1.973e-16 7.343e-15
126 NEURON PROJECTION DEVELOPMENT 33 545 2.281e-16 8.424e-15
127 ACTIVATION OF MAPK ACTIVITY 19 137 2.519e-16 9.228e-15
128 TUBE DEVELOPMENT 33 552 3.313e-16 1.204e-14
129 POSITIVE REGULATION OF GENE EXPRESSION 58 1733 3.428e-16 1.237e-14
130 REGULATION OF DEVELOPMENTAL GROWTH 25 289 3.788e-16 1.356e-14
131 REGULATION OF RESPONSE TO STRESS 53 1468 4.06e-16 1.442e-14
132 RESPONSE TO ABIOTIC STIMULUS 44 1024 4.673e-16 1.647e-14
133 GLYCEROLIPID METABOLIC PROCESS 27 356 6.299e-16 2.204e-14
134 PROTEIN AUTOPHOSPHORYLATION 21 192 8.831e-16 3.066e-14
135 POSITIVE REGULATION OF CELL CYCLE 26 332 1.048e-15 3.611e-14
136 FORMATION OF PRIMARY GERM LAYER 17 110 1.533e-15 5.208e-14
137 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 14 61 1.526e-15 5.208e-14
138 NEURON PROJECTION MORPHOGENESIS 28 402 1.55e-15 5.227e-14
139 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 41 926 2.024e-15 6.775e-14
140 REGULATION OF TRANSPORT 58 1804 2.071e-15 6.883e-14
141 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 58 1805 2.123e-15 7.005e-14
142 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 18 133 2.464e-15 8.073e-14
143 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 38 801 2.83e-15 9.208e-14
144 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 42 983 2.986e-15 9.649e-14
145 CELL PROJECTION ORGANIZATION 40 902 4.478e-15 1.437e-13
146 REGULATION OF CELL CYCLE 41 949 4.655e-15 1.484e-13
147 POSITIVE REGULATION OF CELL DEATH 33 605 4.7e-15 1.488e-13
148 RESPONSE TO STEROID HORMONE 30 497 6.522e-15 2.05e-13
149 UROGENITAL SYSTEM DEVELOPMENT 24 299 8.204e-15 2.562e-13
150 PHOSPHOLIPID METABOLIC PROCESS 26 364 9.449e-15 2.931e-13
151 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 16 103 9.841e-15 3.032e-13
152 POSITIVE REGULATION OF TRANSPORT 40 936 1.521e-14 4.656e-13
153 REGULATION OF GROWTH 33 633 1.707e-14 5.19e-13
154 REGULATION OF NEURON DIFFERENTIATION 31 554 1.739e-14 5.255e-13
155 HEMOSTASIS 24 311 1.968e-14 5.908e-13
156 REGULATION OF CELL MATRIX ADHESION 15 90 2.327e-14 6.94e-13
157 REGULATION OF IMMUNE RESPONSE 38 858 2.513e-14 7.448e-13
158 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 14 74 2.747e-14 8.091e-13
159 NEURON DEVELOPMENT 34 687 2.951e-14 8.637e-13
160 REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 13 60 3.608e-14 1.049e-12
161 APOPTOTIC SIGNALING PATHWAY 23 289 3.691e-14 1.067e-12
162 NEURON DIFFERENTIATION 38 874 4.49e-14 1.29e-12
163 EMBRYONIC MORPHOGENESIS 30 539 5.521e-14 1.576e-12
164 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 35 750 6.66e-14 1.89e-12
165 CELL CHEMOTAXIS 18 162 8.264e-14 2.33e-12
166 RESPONSE TO CYTOKINE 34 714 8.938e-14 2.505e-12
167 REGULATION OF GTPASE ACTIVITY 33 673 9.578e-14 2.669e-12
168 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 15 99 1.009e-13 2.778e-12
169 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 23 303 1.009e-13 2.778e-12
170 EPITHELIUM DEVELOPMENT 39 945 1.042e-13 2.851e-12
171 REGULATION OF CELL PROJECTION ORGANIZATION 30 558 1.359e-13 3.698e-12
172 REGULATION OF NEURON APOPTOTIC PROCESS 19 192 1.379e-13 3.729e-12
173 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 11 39 1.454e-13 3.912e-12
174 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 13 67 1.663e-13 4.447e-12
175 CELL SUBSTRATE JUNCTION ASSEMBLY 11 41 2.692e-13 7.159e-12
176 REGULATION OF CELL DEVELOPMENT 36 836 3.066e-13 8.106e-12
177 GASTRULATION 17 155 5.148e-13 1.353e-11
178 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 17 156 5.726e-13 1.497e-11
179 REGULATION OF APOPTOTIC SIGNALING PATHWAY 24 363 5.781e-13 1.503e-11
180 POSITIVE REGULATION OF CELL DEVELOPMENT 27 472 5.899e-13 1.525e-11
181 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 10 32 6e-13 1.543e-11
182 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 26 437 6.691e-13 1.711e-11
183 GLYCEROLIPID BIOSYNTHETIC PROCESS 19 211 7.599e-13 1.932e-11
184 REGULATION OF CELL DIVISION 21 272 9.109e-13 2.304e-11
185 RESPONSE TO ORGANIC CYCLIC COMPOUND 37 917 9.692e-13 2.438e-11
186 REGULATION OF NEURON PROJECTION DEVELOPMENT 25 408 1.002e-12 2.507e-11
187 GROWTH 25 410 1.117e-12 2.778e-11
188 RESPONSE TO ESTROGEN 19 218 1.364e-12 3.375e-11
189 TISSUE MORPHOGENESIS 28 533 1.669e-12 4.11e-11
190 REGULATION OF LIPID METABOLIC PROCESS 21 282 1.829e-12 4.479e-11
191 REGULATION OF PROTEIN KINASE B SIGNALING 15 121 2.072e-12 5.048e-11
192 NEGATIVE REGULATION OF ANOIKIS 8 17 2.581e-12 6.222e-11
193 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 8 17 2.581e-12 6.222e-11
194 PEPTIDYL SERINE MODIFICATION 16 148 3.187e-12 7.643e-11
195 RESPONSE TO ALCOHOL 23 362 4.107e-12 9.787e-11
196 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 19 232 4.123e-12 9.787e-11
197 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 10 38 4.166e-12 9.84e-11
198 RESPONSE TO INSULIN 18 205 4.795e-12 1.127e-10
199 PHOSPHOLIPID BIOSYNTHETIC PROCESS 19 235 5.173e-12 1.21e-10
200 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 16 153 5.332e-12 1.241e-10
201 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 23 368 5.748e-12 1.331e-10
202 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 11 53 5.829e-12 1.343e-10
203 POSITIVE REGULATION OF GROWTH 19 238 6.47e-12 1.483e-10
204 REPRODUCTIVE SYSTEM DEVELOPMENT 24 408 6.973e-12 1.59e-10
205 NEGATIVE REGULATION OF CELL COMMUNICATION 41 1192 8.048e-12 1.827e-10
206 POSITIVE REGULATION OF NEURON DIFFERENTIATION 21 306 8.711e-12 1.967e-10
207 HEAD DEVELOPMENT 31 709 1.13e-11 2.54e-10
208 POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 10 42 1.251e-11 2.798e-10
209 IMMUNE SYSTEM DEVELOPMENT 28 582 1.35e-11 2.991e-10
210 MULTICELLULAR ORGANISM METABOLIC PROCESS 13 93 1.345e-11 2.991e-10
211 CELL PART MORPHOGENESIS 29 633 1.835e-11 4.047e-10
212 RESPONSE TO ACID CHEMICAL 21 319 1.912e-11 4.196e-10
213 REGULATION OF CELL MORPHOGENESIS 27 552 2.222e-11 4.854e-10
214 REGULATION OF AXONOGENESIS 16 168 2.24e-11 4.871e-10
215 CENTRAL NERVOUS SYSTEM DEVELOPMENT 34 872 2.336e-11 5.056e-10
216 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 11 60 2.46e-11 5.3e-10
217 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 22 360 2.644e-11 5.67e-10
218 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 13 98 2.66e-11 5.679e-10
219 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 28 602 2.977e-11 6.325e-10
220 MYELOID LEUKOCYTE MIGRATION 13 99 3.035e-11 6.39e-10
221 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 13 99 3.035e-11 6.39e-10
222 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 12 79 3.061e-11 6.415e-10
223 RESPONSE TO ESTRADIOL 15 146 3.245e-11 6.772e-10
224 POSITIVE REGULATION OF MITOTIC CELL CYCLE 14 123 3.73e-11 7.749e-10
225 CELL CELL ADHESION 28 608 3.75e-11 7.755e-10
226 REGULATION OF CELL ACTIVATION 25 484 4.103e-11 8.447e-10
227 REGULATION OF PHOSPHOLIPASE ACTIVITY 11 64 5.149e-11 1.056e-09
228 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 21 337 5.341e-11 1.09e-09
229 REGULATION OF PROTEIN LOCALIZATION 35 950 5.442e-11 1.106e-09
230 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 15 152 5.797e-11 1.173e-09
231 REGULATION OF PHOSPHATASE ACTIVITY 14 128 6.425e-11 1.294e-09
232 FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 84 6.455e-11 1.295e-09
233 CELL JUNCTION ASSEMBLY 14 129 7.142e-11 1.426e-09
234 REGULATION OF ANOIKIS 8 24 7.337e-11 1.44e-09
235 POSITIVE REGULATION OF LIPASE ACTIVITY 11 66 7.305e-11 1.44e-09
236 CELLULAR RESPONSE TO STRESS 46 1565 7.248e-11 1.44e-09
237 REGULATION OF PROTEIN PHOSPHATASE TYPE 2A ACTIVITY 8 24 7.337e-11 1.44e-09
238 HOMEOSTATIC PROCESS 42 1337 7.565e-11 1.479e-09
239 POSITIVE CHEMOTAXIS 9 36 8.463e-11 1.648e-09
240 POSITIVE REGULATION OF DNA REPLICATION 12 86 8.578e-11 1.663e-09
241 RESPONSE TO OXYGEN LEVELS 20 311 8.983e-11 1.727e-09
242 POSITIVE REGULATION OF CELL ACTIVATION 20 311 8.983e-11 1.727e-09
243 POSITIVE REGULATION OF DNA METABOLIC PROCESS 16 185 9.629e-11 1.836e-09
244 CELL JUNCTION ORGANIZATION 16 185 9.629e-11 1.836e-09
245 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 10 51 1.002e-10 1.903e-09
246 REGULATION OF DEPHOSPHORYLATION 15 158 1.009e-10 1.909e-09
247 REGULATION OF HEMOPOIESIS 20 314 1.066e-10 2.006e-09
248 PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 8 25 1.069e-10 2.006e-09
249 POSITIVE REGULATION OF AXONOGENESIS 11 69 1.207e-10 2.256e-09
250 REGULATION OF CELLULAR PROTEIN LOCALIZATION 26 552 1.225e-10 2.281e-09
251 RESPONSE TO DRUG 23 431 1.374e-10 2.547e-09
252 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 15 162 1.441e-10 2.661e-09
253 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 25 514 1.465e-10 2.694e-09
254 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 10 53 1.502e-10 2.751e-09
255 GLAND DEVELOPMENT 22 395 1.577e-10 2.878e-09
256 CELLULAR RESPONSE TO CYTOKINE STIMULUS 27 606 1.811e-10 3.291e-09
257 CONNECTIVE TISSUE DEVELOPMENT 16 194 1.959e-10 3.547e-09
258 NEGATIVE REGULATION OF CELL DIFFERENTIATION 27 609 2.02e-10 3.643e-09
259 NEPHRON DEVELOPMENT 13 115 2.074e-10 3.726e-09
260 LEUKOCYTE DIFFERENTIATION 19 292 2.223e-10 3.964e-09
261 MORPHOGENESIS OF A BRANCHING STRUCTURE 15 167 2.218e-10 3.964e-09
262 POSITIVE REGULATION OF STAT CASCADE 11 73 2.272e-10 4.02e-09
263 POSITIVE REGULATION OF JAK STAT CASCADE 11 73 2.272e-10 4.02e-09
264 RESPONSE TO FIBROBLAST GROWTH FACTOR 13 116 2.315e-10 4.079e-09
265 ENDODERMAL CELL DIFFERENTIATION 9 40 2.372e-10 4.164e-09
266 REGULATION OF CELLULAR LOCALIZATION 40 1277 2.549e-10 4.459e-09
267 LEUKOCYTE CHEMOTAXIS 13 117 2.58e-10 4.497e-09
268 NEGATIVE REGULATION OF NEURON DEATH 15 171 3.099e-10 5.381e-09
269 REGULATION OF LEUKOCYTE DIFFERENTIATION 17 232 3.321e-10 5.744e-09
270 CELL CELL SIGNALING 30 767 3.736e-10 6.438e-09
271 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 12 98 4.089e-10 7.021e-09
272 HOMEOSTASIS OF NUMBER OF CELLS 15 175 4.291e-10 7.341e-09
273 NEURON PROJECTION GUIDANCE 16 205 4.439e-10 7.565e-09
274 REGULATION OF CELL CELL ADHESION 21 380 4.858e-10 8.251e-09
275 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 6 11 5.059e-10 8.56e-09
276 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 12 100 5.193e-10 8.754e-09
277 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 8 30 5.536e-10 9.299e-09
278 SINGLE ORGANISM BEHAVIOR 21 384 5.874e-10 9.832e-09
279 REGULATION OF MITOTIC CELL CYCLE 23 468 6.875e-10 1.147e-08
280 REGULATION OF LIPASE ACTIVITY 11 83 9.418e-10 1.565e-08
281 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 13 131 1.067e-09 1.766e-08
282 OSSIFICATION 17 251 1.117e-09 1.842e-08
283 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 19 323 1.212e-09 1.992e-08
284 MORPHOGENESIS OF AN EPITHELIUM 21 400 1.226e-09 2.009e-08
285 SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 8 33 1.279e-09 2.08e-08
286 EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 8 33 1.279e-09 2.08e-08
287 CELLULAR LIPID METABOLIC PROCESS 32 913 1.393e-09 2.259e-08
288 LEUKOCYTE CELL CELL ADHESION 17 255 1.422e-09 2.297e-08
289 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 12 109 1.428e-09 2.299e-08
290 POSITIVE REGULATION OF HEMOPOIESIS 14 163 1.624e-09 2.606e-08
291 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 34 1.657e-09 2.65e-08
292 POSITIVE REGULATION OF NEURON DEATH 10 67 1.684e-09 2.684e-08
293 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 20 370 1.884e-09 2.992e-08
294 RESPONSE TO AMINO ACID 12 112 1.959e-09 3.101e-08
295 ENDODERM FORMATION 9 50 1.987e-09 3.135e-08
296 TELENCEPHALON DEVELOPMENT 16 228 2.102e-09 3.304e-08
297 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 16 229 2.239e-09 3.509e-08
298 REGULATION OF DNA METABOLIC PROCESS 19 340 2.83e-09 4.419e-08
299 ENDODERM DEVELOPMENT 10 71 3.025e-09 4.707e-08
300 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 14 171 3.037e-09 4.711e-08
301 LYMPHOCYTE ACTIVATION 19 342 3.117e-09 4.818e-08
302 REGULATION OF CELLULAR RESPONSE TO STRESS 27 691 3.159e-09 4.867e-08
303 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 6 14 3.204e-09 4.92e-08
304 REGULATION OF JAK STAT CASCADE 13 144 3.435e-09 5.223e-08
305 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 8 37 3.432e-09 5.223e-08
306 REGULATION OF STAT CASCADE 13 144 3.435e-09 5.223e-08
307 CELLULAR RESPONSE TO INSULIN STIMULUS 13 146 4.068e-09 6.165e-08
308 FC RECEPTOR SIGNALING PATHWAY 15 206 4.115e-09 6.217e-08
309 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 7 25 4.718e-09 7.104e-08
310 POSITIVE REGULATION OF CELL CELL ADHESION 16 243 5.262e-09 7.897e-08
311 REGULATION OF PHOSPHOLIPASE C ACTIVITY 8 39 5.373e-09 8.038e-08
312 MEMORY 11 98 5.711e-09 8.517e-08
313 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 21 437 5.893e-09 8.761e-08
314 MESODERMAL CELL DIFFERENTIATION 7 26 6.399e-09 9.483e-08
315 POSITIVE REGULATION OF CELL MATRIX ADHESION 8 40 6.656e-09 9.832e-08
316 REGULATION OF INTRACELLULAR TRANSPORT 25 621 7.045e-09 1.037e-07
317 PALLIUM DEVELOPMENT 13 153 7.203e-09 1.057e-07
318 AMEBOIDAL TYPE CELL MIGRATION 13 154 7.796e-09 1.141e-07
319 COGNITION 16 251 8.353e-09 1.218e-07
320 POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 16 8.398e-09 1.221e-07
321 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 7 27 8.563e-09 1.237e-07
322 HETEROTYPIC CELL CELL ADHESION 7 27 8.563e-09 1.237e-07
323 ERBB SIGNALING PATHWAY 10 79 8.784e-09 1.265e-07
324 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 12 128 9.107e-09 1.308e-07
325 LIPID BIOSYNTHETIC PROCESS 23 539 1.006e-08 1.441e-07
326 CYTOKINE MEDIATED SIGNALING PATHWAY 21 452 1.063e-08 1.517e-07
327 REGULATION OF FIBROBLAST PROLIFERATION 10 81 1.125e-08 1.596e-07
328 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 10 81 1.125e-08 1.596e-07
329 INFLAMMATORY RESPONSE 21 454 1.148e-08 1.623e-07
330 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 12 131 1.185e-08 1.671e-07
331 REGULATION OF RESPONSE TO WOUNDING 20 413 1.217e-08 1.711e-07
332 LEUKOCYTE ACTIVATION 20 414 1.267e-08 1.776e-07
333 PLATELET DEGRANULATION 11 107 1.456e-08 2.035e-07
334 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 8 44 1.481e-08 2.063e-07
335 TISSUE MIGRATION 10 84 1.609e-08 2.235e-07
336 REPRODUCTION 37 1297 1.64e-08 2.272e-07
337 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 12 135 1.666e-08 2.301e-07
338 SPROUTING ANGIOGENESIS 8 45 1.785e-08 2.457e-07
339 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 12 136 1.811e-08 2.486e-07
340 RESPIRATORY SYSTEM DEVELOPMENT 14 197 1.875e-08 2.565e-07
341 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 7 30 1.912e-08 2.609e-07
342 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 10 86 2.027e-08 2.758e-07
343 CELL CYCLE G1 S PHASE TRANSITION 11 111 2.145e-08 2.902e-07
344 G1 S TRANSITION OF MITOTIC CELL CYCLE 11 111 2.145e-08 2.902e-07
345 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 14 200 2.271e-08 3.062e-07
346 HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE 7 31 2.448e-08 3.292e-07
347 OVULATION CYCLE PROCESS 10 88 2.538e-08 3.404e-07
348 TISSUE HOMEOSTASIS 13 171 2.75e-08 3.677e-07
349 FC EPSILON RECEPTOR SIGNALING PATHWAY 12 142 2.943e-08 3.919e-07
350 REGULATION OF CELL SIZE 13 172 2.948e-08 3.919e-07
351 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 9 68 3.328e-08 4.387e-07
352 REGULATION OF CELL JUNCTION ASSEMBLY 9 68 3.328e-08 4.387e-07
353 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 9 68 3.328e-08 4.387e-07
354 RESPONSE TO TOXIC SUBSTANCE 15 241 3.408e-08 4.48e-07
355 LIPID METABOLIC PROCESS 34 1158 3.432e-08 4.498e-07
356 CELLULAR RESPONSE TO ACID CHEMICAL 13 175 3.622e-08 4.694e-07
357 GLIOGENESIS 13 175 3.622e-08 4.694e-07
358 GLOMERULUS DEVELOPMENT 8 49 3.604e-08 4.694e-07
359 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 8 49 3.604e-08 4.694e-07
360 FOREBRAIN DEVELOPMENT 18 357 3.67e-08 4.743e-07
361 MAMMARY GLAND DEVELOPMENT 11 117 3.726e-08 4.803e-07
362 MITOCHONDRIAL MEMBRANE ORGANIZATION 10 92 3.912e-08 5.028e-07
363 CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS 6 20 3.927e-08 5.033e-07
364 LYMPHOCYTE DIFFERENTIATION 14 209 3.956e-08 5.057e-07
365 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 11 118 4.073e-08 5.177e-07
366 MESODERM DEVELOPMENT 11 118 4.073e-08 5.177e-07
367 REGULATION OF ADHERENS JUNCTION ORGANIZATION 8 50 4.253e-08 5.392e-07
368 REGULATION OF MEMBRANE PERMEABILITY 9 70 4.315e-08 5.455e-07
369 REGULATION OF HOMEOSTATIC PROCESS 20 447 4.516e-08 5.694e-07
370 POSITIVE REGULATION OF CELL CYCLE PROCESS 15 247 4.72e-08 5.933e-07
371 SENSORY ORGAN DEVELOPMENT 21 493 4.73e-08 5.933e-07
372 TUBE MORPHOGENESIS 17 323 4.8e-08 6.004e-07
373 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 9 71 4.897e-08 6.109e-07
374 REGULATION OF LEUKOCYTE MIGRATION 12 149 5.037e-08 6.224e-07
375 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 22 541 5.043e-08 6.224e-07
376 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 14 213 5.018e-08 6.224e-07
377 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 22 541 5.043e-08 6.224e-07
378 REGULATION OF ORGANELLE ORGANIZATION 34 1178 5.191e-08 6.389e-07
379 RESPONSE TO KETONE 13 182 5.763e-08 7.075e-07
380 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 14 216 5.977e-08 7.318e-07
381 SKELETAL SYSTEM DEVELOPMENT 20 455 6.035e-08 7.371e-07
382 INTRINSIC APOPTOTIC SIGNALING PATHWAY 12 152 6.285e-08 7.655e-07
383 MAMMARY GLAND EPITHELIUM DEVELOPMENT 8 53 6.836e-08 8.284e-07
384 CELLULAR RESPONSE TO AMINO ACID STIMULUS 8 53 6.836e-08 8.284e-07
385 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 7 36 7.439e-08 8.967e-07
386 POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 7 36 7.439e-08 8.967e-07
387 DEVELOPMENTAL GROWTH 17 333 7.46e-08 8.969e-07
388 HEMIDESMOSOME ASSEMBLY 5 12 8.449e-08 1.011e-06
389 CELL ADHESION MEDIATED BY INTEGRIN 5 12 8.449e-08 1.011e-06
390 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 32 1087 8.658e-08 1.033e-06
391 RHYTHMIC PROCESS 16 298 9.196e-08 1.094e-06
392 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 55 9.227e-08 1.095e-06
393 REGULATED EXOCYTOSIS 14 224 9.396e-08 1.112e-06
394 POSITIVE REGULATION OF IMMUNE RESPONSE 22 563 1.011e-07 1.194e-06
395 RESPONSE TO REACTIVE OXYGEN SPECIES 13 191 1.016e-07 1.197e-06
396 BEHAVIOR 21 516 1.021e-07 1.2e-06
397 ACTIVATION OF IMMUNE RESPONSE 19 427 1.087e-07 1.274e-06
398 CHEMICAL HOMEOSTASIS 28 874 1.101e-07 1.287e-06
399 CELLULAR RESPONSE TO EXTERNAL STIMULUS 15 264 1.13e-07 1.317e-06
400 REGULATION OF DNA REPLICATION 12 161 1.185e-07 1.379e-06
401 ENDOTHELIAL CELL MIGRATION 8 57 1.23e-07 1.427e-06
402 REGULATION OF POSITIVE CHEMOTAXIS 6 24 1.317e-07 1.525e-06
403 ERBB2 SIGNALING PATHWAY 7 39 1.335e-07 1.538e-06
404 PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 7 39 1.335e-07 1.538e-06
405 NEGATIVE REGULATION OF CELL CYCLE 19 433 1.349e-07 1.55e-06
406 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 22 573 1.371e-07 1.571e-06
407 REGULATION OF HOMOTYPIC CELL CELL ADHESION 16 307 1.381e-07 1.579e-06
408 CEREBRAL CORTEX DEVELOPMENT 10 105 1.393e-07 1.585e-06
409 ODONTOGENESIS 10 105 1.393e-07 1.585e-06
410 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 9 80 1.407e-07 1.593e-06
411 INSULIN RECEPTOR SIGNALING PATHWAY 9 80 1.407e-07 1.593e-06
412 REGULATION OF CELL GROWTH 18 391 1.441e-07 1.628e-06
413 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 14 232 1.449e-07 1.633e-06
414 INTERACTION WITH HOST 11 134 1.515e-07 1.702e-06
415 REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 8 59 1.622e-07 1.818e-06
416 CELL GROWTH 11 135 1.634e-07 1.828e-06
417 RESPONSE TO OXIDATIVE STRESS 17 352 1.65e-07 1.841e-06
418 CELLULAR EXTRAVASATION 6 25 1.718e-07 1.913e-06
419 GLIAL CELL DIFFERENTIATION 11 136 1.762e-07 1.957e-06
420 RESPONSE TO EXTRACELLULAR STIMULUS 19 441 1.79e-07 1.983e-06
421 REGULATION OF GLUCOSE IMPORT 8 60 1.855e-07 2.05e-06
422 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 14 2.1e-07 2.316e-06
423 OVARIAN FOLLICLE DEVELOPMENT 8 61 2.116e-07 2.328e-06
424 SECRETION 22 588 2.136e-07 2.344e-06
425 CELL CYCLE 35 1316 2.338e-07 2.559e-06
426 RESPONSE TO LIGHT STIMULUS 15 280 2.419e-07 2.642e-06
427 REGULATION OF LEUKOCYTE PROLIFERATION 13 206 2.446e-07 2.659e-06
428 ORGANOPHOSPHATE BIOSYNTHETIC PROCESS 19 450 2.442e-07 2.659e-06
429 NEGATIVE REGULATION OF CELL PROLIFERATION 23 643 2.466e-07 2.674e-06
430 EMBRYONIC ORGAN DEVELOPMENT 18 406 2.515e-07 2.715e-06
431 CELL CYCLE PROCESS 31 1081 2.515e-07 2.715e-06
432 REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 7 43 2.701e-07 2.909e-06
433 OVULATION CYCLE 10 113 2.79e-07 2.998e-06
434 TISSUE REMODELING 9 87 2.924e-07 3.135e-06
435 REGULATION OF METAL ION TRANSPORT 16 325 2.986e-07 3.194e-06
436 RESPONSE TO MECHANICAL STIMULUS 13 210 3.052e-07 3.257e-06
437 CELLULAR RESPONSE TO LIPID 19 457 3.091e-07 3.291e-06
438 RESPONSE TO CORTICOSTEROID 12 176 3.128e-07 3.322e-06
439 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 11 144 3.149e-07 3.337e-06
440 SKIN DEVELOPMENT 13 211 3.223e-07 3.408e-06
441 RESPONSE TO RADIATION 18 413 3.232e-07 3.41e-06
442 REGULATION OF SYSTEM PROCESS 20 507 3.431e-07 3.612e-06
443 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 9 89 3.559e-07 3.739e-06
444 FEMALE SEX DIFFERENTIATION 10 116 3.568e-07 3.74e-06
445 CARTILAGE DEVELOPMENT 11 147 3.877e-07 4.054e-06
446 MESODERM MORPHOGENESIS 8 66 3.948e-07 4.119e-06
447 REGULATION OF CELLULAR COMPONENT BIOGENESIS 25 767 4.088e-07 4.256e-06
448 DIGESTIVE SYSTEM DEVELOPMENT 11 148 4.15e-07 4.309e-06
449 HEART DEVELOPMENT 19 466 4.158e-07 4.309e-06
450 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 7 46 4.37e-07 4.518e-06
451 REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 29 4.453e-07 4.584e-06
452 POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 29 4.453e-07 4.584e-06
453 DEFENSE RESPONSE 33 1231 4.563e-07 4.687e-06
454 CELL CYCLE PHASE TRANSITION 14 255 4.586e-07 4.7e-06
455 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 12 184 5.046e-07 5.148e-06
456 CELLULAR RESPONSE TO OXIDATIVE STRESS 12 184 5.046e-07 5.148e-06
457 RESPONSE TO ANTIBIOTIC 7 47 5.089e-07 5.171e-06
458 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 7 47 5.089e-07 5.171e-06
459 RESPONSE TO GROWTH HORMONE 6 30 5.518e-07 5.594e-06
460 RESPONSE TO ACTIVITY 8 69 5.598e-07 5.662e-06
461 RESPONSE TO GLUCAGON 7 48 5.906e-07 5.949e-06
462 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 7 48 5.906e-07 5.949e-06
463 T CELL DIFFERENTIATION 10 123 6.163e-07 6.194e-06
464 REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 5 17 6.329e-07 6.347e-06
465 CELLULAR RESPONSE TO ABIOTIC STIMULUS 14 263 6.648e-07 6.652e-06
466 REGULATION OF PLATELET ACTIVATION 6 31 6.784e-07 6.773e-06
467 GLAND MORPHOGENESIS 9 97 7.452e-07 7.409e-06
468 REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 9 97 7.452e-07 7.409e-06
469 SEX DIFFERENTIATION 14 266 7.614e-07 7.554e-06
470 SECRETION BY CELL 19 486 7.828e-07 7.75e-06
471 STAT CASCADE 7 50 7.874e-07 7.762e-06
472 JAK STAT CASCADE 7 50 7.874e-07 7.762e-06
473 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 9 98 8.133e-07 8e-06
474 REGULATION OF COLLATERAL SPROUTING 5 18 8.689e-07 8.512e-06
475 REGULATION OF ORGAN GROWTH 8 73 8.686e-07 8.512e-06
476 POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION 7 51 9.047e-07 8.843e-06
477 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 12 195 9.366e-07 9.137e-06
478 LIMBIC SYSTEM DEVELOPMENT 9 100 9.657e-07 9.401e-06
479 MULTICELLULAR ORGANISMAL HOMEOSTASIS 14 272 9.932e-07 9.647e-06
480 KIDNEY VASCULATURE DEVELOPMENT 5 19 1.169e-06 1.131e-05
481 RENAL SYSTEM VASCULATURE DEVELOPMENT 5 19 1.169e-06 1.131e-05
482 REGULATION OF LYMPHOCYTE DIFFERENTIATION 10 132 1.183e-06 1.142e-05
483 PROTEIN KINASE B SIGNALING 6 34 1.207e-06 1.163e-05
484 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 16 365 1.388e-06 1.334e-05
485 EMBRYONIC HEMOPOIESIS 5 20 1.546e-06 1.483e-05
486 INTERSPECIES INTERACTION BETWEEN ORGANISMS 22 662 1.553e-06 1.484e-05
487 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 22 662 1.553e-06 1.484e-05
488 GLUCOSE HOMEOSTASIS 11 170 1.645e-06 1.565e-05
489 CARBOHYDRATE HOMEOSTASIS 11 170 1.645e-06 1.565e-05
490 ORGANOPHOSPHATE METABOLIC PROCESS 26 885 1.661e-06 1.578e-05
491 RESPONSE TO BIOTIC STIMULUS 26 886 1.696e-06 1.607e-05
492 REGULATION OF T CELL DIFFERENTIATION 9 107 1.71e-06 1.617e-05
493 ANATOMICAL STRUCTURE HOMEOSTASIS 14 285 1.724e-06 1.627e-05
494 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 7 56 1.735e-06 1.634e-05
495 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 8 80 1.761e-06 1.655e-05
496 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 8 81 1.936e-06 1.817e-05
497 RESPONSE TO HYDROGEN PEROXIDE 9 109 1.998e-06 1.87e-05
498 REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 5 21 2.012e-06 1.88e-05
499 REGULATION OF SYNAPTIC PLASTICITY 10 140 2.024e-06 1.887e-05
500 NEGATIVE REGULATION OF PHOSPHORYLATION 17 422 2.04e-06 1.899e-05
501 REGULATION OF CATABOLIC PROCESS 23 731 2.234e-06 2.075e-05
502 NEGATIVE REGULATION OF MOLECULAR FUNCTION 29 1079 2.354e-06 2.182e-05
503 SYSTEM PROCESS 40 1785 2.364e-06 2.186e-05
504 CELLULAR RESPONSE TO GLUCAGON STIMULUS 6 38 2.395e-06 2.206e-05
505 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 6 38 2.395e-06 2.206e-05
506 MITOCHONDRIAL TRANSPORT 11 177 2.439e-06 2.243e-05
507 POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 5 22 2.582e-06 2.37e-05
508 RESPONSE TO INORGANIC SUBSTANCE 18 479 2.7e-06 2.473e-05
509 CHONDROCYTE DIFFERENTIATION 7 60 2.789e-06 2.55e-05
510 MUSCLE STRUCTURE DEVELOPMENT 17 432 2.796e-06 2.551e-05
511 T CELL RECEPTOR SIGNALING PATHWAY 10 146 2.959e-06 2.694e-05
512 POSITIVE REGULATION OF STEM CELL PROLIFERATION 7 61 3.123e-06 2.839e-05
513 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 10 147 3.146e-06 2.854e-05
514 NEUROTROPHIN SIGNALING PATHWAY 5 23 3.272e-06 2.962e-05
515 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 87 3.336e-06 2.974e-05
516 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 87 3.336e-06 2.974e-05
517 VIRAL ENTRY INTO HOST CELL 8 87 3.336e-06 2.974e-05
518 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 8 87 3.336e-06 2.974e-05
519 MOVEMENT IN HOST ENVIRONMENT 8 87 3.336e-06 2.974e-05
520 ENTRY INTO HOST 8 87 3.336e-06 2.974e-05
521 ENTRY INTO HOST CELL 8 87 3.336e-06 2.974e-05
522 IMMUNE EFFECTOR PROCESS 18 486 3.306e-06 2.974e-05
523 POSITIVE REGULATION OF CELL GROWTH 10 148 3.344e-06 2.975e-05
524 REGULATION OF PEPTIDASE ACTIVITY 16 392 3.483e-06 3.093e-05
525 POSITIVE REGULATION OF NUCLEAR DIVISION 7 62 3.49e-06 3.093e-05
526 NEGATIVE REGULATION OF CELL DEVELOPMENT 14 303 3.522e-06 3.115e-05
527 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 9 117 3.604e-06 3.182e-05
528 REGULATION OF COAGULATION 8 88 3.638e-06 3.2e-05
529 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 8 88 3.638e-06 3.2e-05
530 REGULATION OF ION TRANSPORT 20 592 3.727e-06 3.272e-05
531 RESPONSE TO HEAT 8 89 3.962e-06 3.465e-05
532 EPITHELIAL CELL PROLIFERATION 8 89 3.962e-06 3.465e-05
533 REGULATION OF DENDRITE DEVELOPMENT 9 120 4.442e-06 3.878e-05
534 EXOCYTOSIS 14 310 4.583e-06 3.993e-05
535 CELL CYCLE ARREST 10 154 4.775e-06 4.132e-05
536 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 10 154 4.775e-06 4.132e-05
537 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 12 228 4.778e-06 4.132e-05
538 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 9 121 4.757e-06 4.132e-05
539 MESENCHYME DEVELOPMENT 11 190 4.839e-06 4.177e-05
540 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 11 191 5.088e-06 4.352e-05
541 REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 6 43 5.065e-06 4.352e-05
542 CEREBRAL CORTEX CELL MIGRATION 6 43 5.065e-06 4.352e-05
543 RESPONSE TO NUTRIENT 11 191 5.088e-06 4.352e-05
544 HISTONE PHOSPHORYLATION 5 25 5.08e-06 4.352e-05
545 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 4 12 5.171e-06 4.414e-05
546 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 19 554 5.319e-06 4.533e-05
547 BONE DEVELOPMENT 10 156 5.357e-06 4.557e-05
548 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 16 406 5.437e-06 4.617e-05
549 NEGATIVE REGULATION OF TRANSPORT 17 458 6.076e-06 5.15e-05
550 EAR DEVELOPMENT 11 195 6.204e-06 5.239e-05
551 REGULATION OF MUSCLE SYSTEM PROCESS 11 195 6.204e-06 5.239e-05
552 DEVELOPMENTAL PROGRAMMED CELL DEATH 5 26 6.236e-06 5.257e-05
553 FC GAMMA RECEPTOR SIGNALING PATHWAY 8 95 6.466e-06 5.431e-05
554 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 8 95 6.466e-06 5.431e-05
555 MULTICELLULAR ORGANISMAL RESPONSE TO STRESS 7 68 6.529e-06 5.454e-05
556 ORGAN GROWTH 7 68 6.529e-06 5.454e-05
557 REGULATION OF NEUROLOGICAL SYSTEM PROCESS 7 68 6.529e-06 5.454e-05
558 REGULATION OF WOUND HEALING 9 126 6.632e-06 5.52e-05
559 RESPONSE TO UV 9 126 6.632e-06 5.52e-05
560 EXOCRINE SYSTEM DEVELOPMENT 6 45 6.652e-06 5.527e-05
561 POSITIVE REGULATION OF ION TRANSPORT 12 236 6.792e-06 5.634e-05
562 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 11 197 6.837e-06 5.661e-05
563 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 13 278 6.954e-06 5.747e-05
564 REGULATION OF LEUKOCYTE CHEMOTAXIS 8 96 6.992e-06 5.769e-05
565 SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 9 127 7.075e-06 5.826e-05
566 REGENERATION 10 161 7.088e-06 5.827e-05
567 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 17 465 7.413e-06 6.073e-05
568 POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 4 13 7.408e-06 6.073e-05
569 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 11 199 7.526e-06 6.155e-05
570 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 5 27 7.59e-06 6.195e-05
571 CELLULAR HOMEOSTASIS 21 676 7.696e-06 6.271e-05
572 SENSORY ORGAN MORPHOGENESIS 12 239 7.721e-06 6.281e-05
573 RESPONSE TO VITAMIN 8 98 8.153e-06 6.621e-05
574 REGULATION OF ANATOMICAL STRUCTURE SIZE 17 472 9.009e-06 7.303e-05
575 REGULATION OF SPROUTING ANGIOGENESIS 5 28 9.162e-06 7.414e-05
576 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 21 684 9.198e-06 7.43e-05
577 MITOTIC DNA INTEGRITY CHECKPOINT 8 100 9.472e-06 7.625e-05
578 REGULATION OF GLUCOSE TRANSPORT 8 100 9.472e-06 7.625e-05
579 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 6 48 9.766e-06 7.848e-05
580 REGULATION OF EXTENT OF CELL GROWTH 8 101 1.02e-05 8.18e-05
581 POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 4 14 1.029e-05 8.224e-05
582 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 4 14 1.029e-05 8.224e-05
583 HIPPOCAMPUS DEVELOPMENT 7 73 1.05e-05 8.355e-05
584 G1 DNA DAMAGE CHECKPOINT 7 73 1.05e-05 8.355e-05
585 REGULATION OF PLASMA MEMBRANE ORGANIZATION 7 73 1.05e-05 8.355e-05
586 REGULATION OF DENDRITE MORPHOGENESIS 7 74 1.15e-05 9.124e-05
587 REGULATION OF CYTOPLASMIC TRANSPORT 17 481 1.151e-05 9.124e-05
588 REGULATION OF MUSCLE ORGAN DEVELOPMENT 8 103 1.179e-05 9.327e-05
589 REGULATION OF CALCIUM ION TRANSPORT 11 209 1.196e-05 9.449e-05
590 RESPONSE TO ETHANOL 9 136 1.233e-05 9.726e-05
591 POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 7 75 1.257e-05 9.883e-05
592 GRANULOCYTE MIGRATION 7 75 1.257e-05 9.883e-05
593 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 10 172 1.267e-05 9.928e-05
594 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 8 104 1.266e-05 9.928e-05
595 NEGATIVE REGULATION OF TOR SIGNALING 5 30 1.306e-05 0.0001022
596 REGULATION OF DEFENSE RESPONSE 22 759 1.368e-05 0.0001067
597 EPIDERMIS DEVELOPMENT 12 253 1.369e-05 0.0001067
598 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 4 15 1.391e-05 0.0001077
599 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 4 15 1.391e-05 0.0001077
600 JAK STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY 4 15 1.391e-05 0.0001077
601 NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 4 15 1.391e-05 0.0001077
602 MITOTIC CELL CYCLE CHECKPOINT 9 139 1.47e-05 0.0001134
603 REGULATION OF CELL SHAPE 9 139 1.47e-05 0.0001134
604 MITOTIC CELL CYCLE 22 766 1.576e-05 0.0001214
605 MODULATION OF SYNAPTIC TRANSMISSION 13 301 1.623e-05 0.0001248
606 REGULATION OF OSSIFICATION 10 178 1.708e-05 0.0001311
607 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 23 829 1.733e-05 0.0001328
608 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 6 53 1.75e-05 0.0001335
609 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 6 53 1.75e-05 0.0001335
610 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 6 53 1.75e-05 0.0001335
611 PROTEIN COMPLEX SUBUNIT ORGANIZATION 34 1527 1.762e-05 0.0001342
612 REGULATION OF MITOCHONDRION ORGANIZATION 11 218 1.774e-05 0.0001347
613 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 11 218 1.774e-05 0.0001347
614 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 8 109 1.786e-05 0.0001354
615 SALIVARY GLAND DEVELOPMENT 5 32 1.815e-05 0.0001369
616 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 5 32 1.815e-05 0.0001369
617 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 5 32 1.815e-05 0.0001369
618 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN 4 16 1.84e-05 0.0001381
619 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 4 16 1.84e-05 0.0001381
620 REGULATION OF DEVELOPMENTAL PIGMENTATION 4 16 1.84e-05 0.0001381
621 NEURON MIGRATION 8 110 1.909e-05 0.0001431
622 CELLULAR RESPONSE TO MECHANICAL STIMULUS 7 80 1.927e-05 0.0001441
623 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 11 220 1.931e-05 0.0001442
624 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 9 144 1.951e-05 0.0001455
625 CELLULAR RESPONSE TO DNA DAMAGE STIMULUS 21 720 1.98e-05 0.0001474
626 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 8 111 2.04e-05 0.0001516
627 REGULATION OF MYELOID CELL DIFFERENTIATION 10 183 2.17e-05 0.0001606
628 REGULATION OF PROTEIN IMPORT 10 183 2.17e-05 0.0001606
629 REGULATION OF OSTEOBLAST DIFFERENTIATION 8 112 2.177e-05 0.0001606
630 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 9 146 2.178e-05 0.0001606
631 ZYMOGEN ACTIVATION 8 112 2.177e-05 0.0001606
632 NEGATIVE REGULATION OF CELL ADHESION 11 223 2.189e-05 0.0001612
633 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 19 616 2.348e-05 0.0001726
634 POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 4 17 2.387e-05 0.0001749
635 POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 4 17 2.387e-05 0.0001749
636 RESPONSE TO TEMPERATURE STIMULUS 9 148 2.426e-05 0.0001775
637 ORGAN REGENERATION 7 83 2.453e-05 0.0001792
638 REGULATION OF MESENCHYMAL CELL PROLIFERATION 5 34 2.466e-05 0.0001799
639 APOPTOTIC MITOCHONDRIAL CHANGES 6 57 2.673e-05 0.0001946
640 REGULATION OF VESICLE MEDIATED TRANSPORT 16 462 2.684e-05 0.0001951
641 POSITIVE REGULATION OF PROTEOLYSIS 14 363 2.702e-05 0.0001961
642 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 10 188 2.736e-05 0.0001983
643 BONE REMODELING 5 35 2.853e-05 0.0002058
644 REGULATION OF GLYCOGEN METABOLIC PROCESS 5 35 2.853e-05 0.0002058
645 CELLULAR CHEMICAL HOMEOSTASIS 18 570 2.853e-05 0.0002058
646 EPHRIN RECEPTOR SIGNALING PATHWAY 7 85 2.866e-05 0.0002064
647 CIRCULATORY SYSTEM PROCESS 14 366 2.957e-05 0.0002127
648 STEM CELL DIFFERENTIATION 10 190 2.995e-05 0.0002148
649 PHAGOCYTOSIS 10 190 2.995e-05 0.0002148
650 CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS 4 18 3.044e-05 0.0002179
651 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 13 321 3.18e-05 0.0002273
652 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 6 59 3.262e-05 0.0002321
653 POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 6 59 3.262e-05 0.0002321
654 VASCULOGENESIS 6 59 3.262e-05 0.0002321
655 RESPONSE TO ENDOPLASMIC RETICULUM STRESS 11 233 3.278e-05 0.0002329
656 REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 5 36 3.286e-05 0.0002331
657 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 7 87 3.334e-05 0.0002361
658 LEUKOCYTE PROLIFERATION 7 88 3.591e-05 0.0002528
659 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 7 88 3.591e-05 0.0002528
660 REGULATION OF STEM CELL PROLIFERATION 7 88 3.591e-05 0.0002528
661 CELL CYCLE CHECKPOINT 10 194 3.578e-05 0.0002528
662 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 5 37 3.767e-05 0.000264
663 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 5 37 3.767e-05 0.000264
664 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 5 37 3.767e-05 0.000264
665 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 19 3.825e-05 0.0002676
666 MESONEPHROS DEVELOPMENT 7 90 4.153e-05 0.0002901
667 REGULATION OF TRANSPORTER ACTIVITY 10 198 4.254e-05 0.0002968
668 POSITIVE REGULATION OF ORGAN GROWTH 5 38 4.302e-05 0.0002997
669 FOREBRAIN CELL MIGRATION 6 62 4.338e-05 0.0003013
670 REGULATION OF TISSUE REMODELING 6 62 4.338e-05 0.0003013
671 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 25 1004 4.432e-05 0.0003073
672 REGULATION OF ENDOCYTOSIS 10 199 4.44e-05 0.0003074
673 PROTEIN COMPLEX BIOGENESIS 27 1132 4.509e-05 0.0003113
674 PROTEIN COMPLEX ASSEMBLY 27 1132 4.509e-05 0.0003113
675 REGULATION OF ORGAN MORPHOGENESIS 11 242 4.63e-05 0.0003192
676 AMELOGENESIS 4 20 4.742e-05 0.0003255
677 REGULATION OF NEURON PROJECTION REGENERATION 4 20 4.742e-05 0.0003255
678 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN 4 20 4.742e-05 0.0003255
679 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 5 39 4.893e-05 0.0003348
680 ASTROCYTE DIFFERENTIATION 5 39 4.893e-05 0.0003348
681 REGULATION OF CELLULAR COMPONENT SIZE 13 337 5.241e-05 0.0003581
682 REGULATION OF DNA BIOSYNTHETIC PROCESS 7 94 5.495e-05 0.0003749
683 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 6 65 5.68e-05 0.000387
684 REGULATION OF PROTEIN SECRETION 14 389 5.723e-05 0.0003893
685 POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 4 21 5.811e-05 0.0003947
686 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 8 129 6.009e-05 0.0004076
687 MEMBRANE ORGANIZATION 23 899 6.075e-05 0.0004114
688 EPITHELIAL CELL DIFFERENTIATION 16 495 6.109e-05 0.0004132
689 REGULATION OF MULTICELLULAR ORGANISM GROWTH 6 66 6.195e-05 0.0004184
690 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 5 41 6.263e-05 0.0004224
691 MYELOID LEUKOCYTE DIFFERENTIATION 7 96 6.288e-05 0.0004228
692 SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 7 96 6.288e-05 0.0004228
693 RESPONSE TO CARBOHYDRATE 9 168 6.551e-05 0.0004399
694 POSITIVE REGULATION OF CATABOLIC PROCESS 14 395 6.741e-05 0.000452
695 REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS 5 42 7.05e-05 0.0004686
696 POSITIVE REGULATION OF GLUCOSE TRANSPORT 5 42 7.05e-05 0.0004686
697 SOMATIC STEM CELL DIVISION 4 22 7.045e-05 0.0004686
698 ACTIVATION OF PROTEIN KINASE B ACTIVITY 4 22 7.045e-05 0.0004686
699 REGULATION OF CARBOHYDRATE CATABOLIC PROCESS 5 42 7.05e-05 0.0004686
700 ERK1 AND ERK2 CASCADE 4 22 7.045e-05 0.0004686
701 B CELL ACTIVATION 8 132 7.07e-05 0.0004693
702 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 10 211 7.259e-05 0.0004811
703 REGULATION OF TOR SIGNALING 6 68 7.336e-05 0.0004855
704 REGULATION OF CELL CYCLE PROCESS 17 558 7.439e-05 0.0004916
705 CELLULAR MACROMOLECULE LOCALIZATION 28 1234 7.683e-05 0.0005071
706 MESENCHYMAL CELL DIFFERENTIATION 8 134 7.86e-05 0.0005173
707 MULTI MULTICELLULAR ORGANISM PROCESS 10 213 7.852e-05 0.0005173
708 MYELOID LEUKOCYTE MEDIATED IMMUNITY 5 43 7.911e-05 0.0005199
709 VESICLE MEDIATED TRANSPORT 28 1239 8.234e-05 0.0005404
710 POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 4 23 8.459e-05 0.0005528
711 POSITIVE REGULATION OF NEUROLOGICAL SYSTEM PROCESS 4 23 8.459e-05 0.0005528
712 LEUKOCYTE APOPTOTIC PROCESS 4 23 8.459e-05 0.0005528
713 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 6 70 8.638e-05 0.0005637
714 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 5 44 8.851e-05 0.0005768
715 RESPONSE TO ALKALOID 8 137 9.183e-05 0.0005976
716 REGULATION OF INNATE IMMUNE RESPONSE 13 357 9.384e-05 0.0006098
717 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 11 262 9.436e-05 0.0006124
718 PLACENTA DEVELOPMENT 8 138 9.662e-05 0.0006262
719 REGULATION OF MUSCLE TISSUE DEVELOPMENT 7 103 9.834e-05 0.0006364
720 ENDOCHONDRAL BONE MORPHOGENESIS 5 45 9.874e-05 0.0006381
721 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 4 24 0.0001007 0.0006453
722 POSITIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS 4 24 0.0001007 0.0006453
723 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 4 24 0.0001007 0.0006453
724 POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 4 24 0.0001007 0.0006453
725 POSITIVE REGULATION OF RECEPTOR INTERNALIZATION 4 24 0.0001007 0.0006453
726 POSITIVE REGULATION OF ATP METABOLIC PROCESS 4 24 0.0001007 0.0006453
727 IN UTERO EMBRYONIC DEVELOPMENT 12 311 0.0001017 0.0006506
728 POSITIVE REGULATION OF PROTEIN IMPORT 7 104 0.0001045 0.0006672
729 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 7 104 0.0001045 0.0006672
730 REGULATION OF PROTEIN STABILITY 10 221 0.0001065 0.0006791
731 ION HOMEOSTASIS 17 576 0.0001092 0.0006953
732 PEPTIDYL THREONINE MODIFICATION 5 46 0.0001099 0.0006983
733 POSITIVE REGULATION OF DEFENSE RESPONSE 13 364 0.0001139 0.0007229
734 RESPONSE TO PROSTAGLANDIN E 4 25 0.0001189 0.0007537
735 POSITIVE REGULATION OF DEPHOSPHORYLATION 5 47 0.0001219 0.0007718
736 CELLULAR RESPONSE TO OXYGEN LEVELS 8 143 0.0001238 0.0007818
737 RAS PROTEIN SIGNAL TRANSDUCTION 8 143 0.0001238 0.0007818
738 BIOMINERAL TISSUE DEVELOPMENT 6 75 0.0001271 0.0008013
739 REGULATION OF RESPONSE TO CYTOKINE STIMULUS 8 144 0.00013 0.0008183
740 REGULATION OF CELL CYCLE ARREST 7 108 0.0001325 0.0008321
741 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 7 108 0.0001325 0.0008321
742 POSITIVE REGULATION OF CYTOKINE PRODUCTION 13 370 0.0001339 0.0008398
743 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 5 48 0.0001349 0.0008451
744 RESPONSE TO IONIZING RADIATION 8 145 0.0001364 0.0008516
745 SYNAPSE ORGANIZATION 8 145 0.0001364 0.0008516
746 GLIAL CELL DEVELOPMENT 6 76 0.0001368 0.0008533
747 REPLACEMENT OSSIFICATION 4 26 0.0001394 0.000867
748 ENDOCHONDRAL OSSIFICATION 4 26 0.0001394 0.000867
749 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 11 274 0.00014 0.0008698
750 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 13 372 0.0001412 0.0008762
751 REGULATION OF IMMUNE EFFECTOR PROCESS 14 424 0.0001421 0.0008806
752 DNA INTEGRITY CHECKPOINT 8 146 0.000143 0.0008848
753 REGULATION OF SODIUM ION TRANSPORT 6 77 0.0001471 0.000909
754 REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 5 49 0.000149 0.0009136
755 REGULATION OF NUCLEOSIDE METABOLIC PROCESS 5 49 0.000149 0.0009136
756 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 5 49 0.000149 0.0009136
757 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 7 110 0.0001486 0.0009136
758 REGULATION OF ATP METABOLIC PROCESS 5 49 0.000149 0.0009136
759 MULTICELLULAR ORGANISM REPRODUCTION 20 768 0.0001484 0.0009136
760 RESPONSE TO TRANSITION METAL NANOPARTICLE 8 148 0.0001571 0.0009596
761 REGULATION OF PROTEOLYSIS 19 711 0.0001571 0.0009596
762 MALE SEX DIFFERENTIATION 8 148 0.0001571 0.0009596
763 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 6 78 0.000158 0.0009611
764 RENAL TUBULE DEVELOPMENT 6 78 0.000158 0.0009611
765 EYE DEVELOPMENT 12 326 0.0001579 0.0009611
766 POSITIVE REGULATION OF HEART GROWTH 4 27 0.0001623 0.0009846
767 SUBSTRATE DEPENDENT CELL MIGRATION 4 27 0.0001623 0.0009846
768 REGULATION OF COENZYME METABOLIC PROCESS 5 50 0.0001642 0.0009936
769 REGULATION OF COFACTOR METABOLIC PROCESS 5 50 0.0001642 0.0009936
770 REGULATION OF CYTOKINE SECRETION 8 149 0.0001645 0.0009943
771 EAR MORPHOGENESIS 7 112 0.0001663 0.001003
772 PROSTATE GLAND GROWTH 3 11 0.0001696 0.001021
773 BONE MORPHOGENESIS 6 79 0.0001695 0.001021
774 REGULATION OF SYNAPSE ORGANIZATION 7 113 0.0001757 0.001056
775 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 11 282 0.0001799 0.00108
776 NEGATIVE REGULATION OF GROWTH 10 236 0.0001822 0.001092
777 POSITIVE REGULATION OF ENDOCYTOSIS 7 114 0.0001856 0.001111
778 NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 4 28 0.0001878 0.001118
779 LONG TERM MEMORY 4 28 0.0001878 0.001118
780 IMMUNE RESPONSE 25 1100 0.000187 0.001118
781 MAMMARY GLAND DUCT MORPHOGENESIS 4 28 0.0001878 0.001118
782 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 4 28 0.0001878 0.001118
783 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 7 115 0.0001959 0.001164
784 ACTIVATION OF MAPKK ACTIVITY 5 52 0.0001981 0.001176
785 KIDNEY MORPHOGENESIS 6 82 0.0002082 0.001234
786 SENSORY PERCEPTION OF MECHANICAL STIMULUS 8 155 0.0002157 0.001275
787 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 29 0.0002161 0.001275
788 STEM CELL DIVISION 4 29 0.0002161 0.001275
789 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 29 0.0002161 0.001275
790 NEGATIVE REGULATION OF AUTOPHAGY 5 53 0.0002169 0.001276
791 MESONEPHRIC TUBULE MORPHOGENESIS 5 53 0.0002169 0.001276
792 PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE 3 12 0.0002244 0.001315
793 MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 3 12 0.0002244 0.001315
794 POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 3 12 0.0002244 0.001315
795 PROTEIN LOCALIZATION TO NUCLEUS 8 156 0.0002254 0.001319
796 REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 5 54 0.000237 0.001386
797 RESPONSE TO PURINE CONTAINING COMPOUND 8 158 0.0002458 0.001435
798 RESPONSE TO EPIDERMAL GROWTH FACTOR 4 30 0.0002474 0.001439
799 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 4 30 0.0002474 0.001439
800 OSTEOCLAST DIFFERENTIATION 4 30 0.0002474 0.001439
801 POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 14 448 0.0002503 0.001454
802 POSITIVE REGULATION OF CELL CYCLE ARREST 6 85 0.0002534 0.00147
803 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 5 55 0.0002586 0.001496
804 REGULATION OF KIDNEY DEVELOPMENT 5 55 0.0002586 0.001496
805 ACTIN FILAMENT BASED PROCESS 14 450 0.0002619 0.001514
806 REGULATION OF CYTOKINE PRODUCTION 16 563 0.0002666 0.001539
807 POSITIVE REGULATION OF B CELL ACTIVATION 6 86 0.0002701 0.001557
808 NEGATIVE REGULATION OF CATABOLIC PROCESS 9 203 0.0002741 0.001578
809 REGULATION OF AUTOPHAGY 10 249 0.0002802 0.001612
810 NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 4 31 0.0002817 0.001618
811 ENDOCYTOSIS 15 509 0.000283 0.001624
812 NEURONAL STEM CELL DIVISION 3 13 0.0002895 0.001643
813 NEGATIVE REGULATION OF KINASE ACTIVITY 10 250 0.0002893 0.001643
814 INDUCTION OF POSITIVE CHEMOTAXIS 3 13 0.0002895 0.001643
815 REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 3 13 0.0002895 0.001643
816 LEUKOCYTE TETHERING OR ROLLING 3 13 0.0002895 0.001643
817 CELLULAR RESPONSE TO HEPATOCYTE GROWTH FACTOR STIMULUS 3 13 0.0002895 0.001643
818 RESPONSE TO HEPATOCYTE GROWTH FACTOR 3 13 0.0002895 0.001643
819 LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 3 13 0.0002895 0.001643
820 NEUROBLAST DIVISION 3 13 0.0002895 0.001643
821 POSITIVE REGULATION OF RESPONSE TO WOUNDING 8 162 0.0002911 0.00165
822 ENDOCRINE SYSTEM DEVELOPMENT 7 123 0.0002963 0.001677
823 CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM 10 252 0.0003082 0.001743
824 CELL DIVISION 14 460 0.0003269 0.001844
825 KIDNEY EPITHELIUM DEVELOPMENT 7 125 0.0003269 0.001844
826 REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 12 354 0.0003355 0.00189
827 OSTEOBLAST DIFFERENTIATION 7 126 0.0003432 0.001931
828 MIDBRAIN DEVELOPMENT 6 90 0.0003457 0.001942
829 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 8 167 0.0003573 0.002005
830 REGULATION OF BONE RESORPTION 4 33 0.0003605 0.002021
831 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 3 14 0.0003656 0.002031
832 POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 3 14 0.0003656 0.002031
833 EPITHELIAL CELL CELL ADHESION 3 14 0.0003656 0.002031
834 REGULATION OF FIBROBLAST APOPTOTIC PROCESS 3 14 0.0003656 0.002031
835 T CELL MIGRATION 3 14 0.0003656 0.002031
836 BONE MATURATION 3 14 0.0003656 0.002031
837 POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY 3 14 0.0003656 0.002031
838 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 34 1784 0.0003658 0.002031
839 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 10 258 0.0003713 0.002059
840 HEART MORPHOGENESIS 9 212 0.0003769 0.002088
841 REGULATION OF MONOOXYGENASE ACTIVITY 5 60 0.0003893 0.002149
842 LEUKOCYTE HOMEOSTASIS 5 60 0.0003893 0.002149
843 INNER EAR MORPHOGENESIS 6 92 0.0003892 0.002149
844 NEGATIVE REGULATION OF CELL CYCLE PROCESS 9 214 0.0004036 0.002225
845 POSITIVE REGULATION OF SODIUM ION TRANSPORT 4 34 0.0004053 0.002229
846 RESPONSE TO PROSTAGLANDIN 4 34 0.0004053 0.002229
847 RESPONSE TO BACTERIUM 15 528 0.0004161 0.002286
848 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 5 61 0.0004205 0.002308
849 LEARNING 7 131 0.0004343 0.00238
850 STRIATED MUSCLE CELL DIFFERENTIATION 8 173 0.0004523 0.00247
851 RESPONSE TO VITAMIN E 3 15 0.0004536 0.00247
852 T CELL LINEAGE COMMITMENT 3 15 0.0004536 0.00247
853 RESPONSE TO MINERALOCORTICOID 4 35 0.0004539 0.00247
854 T CELL APOPTOTIC PROCESS 3 15 0.0004536 0.00247
855 RESPONSE TO IRON ION 4 35 0.0004539 0.00247
856 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 9 218 0.0004617 0.00251
857 MITOCHONDRION ORGANIZATION 16 594 0.0004801 0.002607
858 CARDIOCYTE DIFFERENTIATION 6 96 0.000489 0.002646
859 REGULATION OF MUSCLE ADAPTATION 5 63 0.0004886 0.002646
860 RESPONSE TO OSMOTIC STRESS 5 63 0.0004886 0.002646
861 NEUROMUSCULAR JUNCTION DEVELOPMENT 4 36 0.0005065 0.002728
862 OLFACTORY LOBE DEVELOPMENT 4 36 0.0005065 0.002728
863 T CELL SELECTION 4 36 0.0005065 0.002728
864 POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS 4 36 0.0005065 0.002728
865 MYELOID LEUKOCYTE ACTIVATION 6 98 0.0005458 0.002936
866 POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 3 16 0.000554 0.00297
867 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 3 16 0.000554 0.00297
868 RESPONSE TO UV B 3 16 0.000554 0.00297
869 POSITIVE REGULATION OF B CELL PROLIFERATION 4 37 0.0005633 0.003006
870 POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 4 37 0.0005633 0.003006
871 REGULATION OF RECEPTOR INTERNALIZATION 4 37 0.0005633 0.003006
872 POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 4 37 0.0005633 0.003006
873 REGULATION OF CHEMOKINE PRODUCTION 5 65 0.0005647 0.003006
874 NEGATIVE REGULATION OF AXONOGENESIS 5 65 0.0005647 0.003006
875 CELLULAR RESPONSE TO RADIATION 7 137 0.0005683 0.003022
876 CELLULAR RESPONSE TO UV 5 66 0.0006059 0.003218
877 MUSCLE TISSUE DEVELOPMENT 10 275 0.0006109 0.003241
878 CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 7 139 0.0006195 0.003283
879 COLLAGEN FIBRIL ORGANIZATION 4 38 0.0006246 0.003302
880 BONE MINERALIZATION 4 38 0.0006246 0.003302
881 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 12 381 0.0006448 0.003405
882 CARDIAC MUSCLE TISSUE DEVELOPMENT 7 140 0.0006465 0.003411
883 NEGATIVE REGULATION OF PLATELET ACTIVATION 3 17 0.0006676 0.003502
884 NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 3 17 0.0006676 0.003502
885 NEGATIVE REGULATION OF LIPID STORAGE 3 17 0.0006676 0.003502
886 MAMMARY GLAND ALVEOLUS DEVELOPMENT 3 17 0.0006676 0.003502
887 MAMMARY GLAND LOBULE DEVELOPMENT 3 17 0.0006676 0.003502
888 EMBRYONIC ORGAN MORPHOGENESIS 10 279 0.0006828 0.003578
889 REGULATION OF GRANULOCYTE CHEMOTAXIS 4 39 0.0006903 0.003597
890 EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 4 39 0.0006903 0.003597
891 CELLULAR RESPONSE TO NUTRIENT 4 39 0.0006903 0.003597
892 LONG TERM SYNAPTIC POTENTIATION 4 39 0.0006903 0.003597
893 PLATELET AGGREGATION 4 39 0.0006903 0.003597
894 EPITHELIAL CELL DEVELOPMENT 8 186 0.000729 0.003794
895 RESPONSE TO METAL ION 11 333 0.0007319 0.003805
896 RESPONSE TO TUMOR NECROSIS FACTOR 9 233 0.0007441 0.003864
897 MAMMARY GLAND MORPHOGENESIS 4 40 0.0007609 0.003943
898 ENDOCRINE PANCREAS DEVELOPMENT 4 40 0.0007609 0.003943
899 REGULATION OF CYTOSKELETON ORGANIZATION 14 502 0.0007736 0.004004
900 REGULATION OF MITOCHONDRIAL DEPOLARIZATION 3 18 0.000795 0.004061
901 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 3 18 0.000795 0.004061
902 REGULATION OF CELL MATURATION 3 18 0.000795 0.004061
903 ORGAN MATURATION 3 18 0.000795 0.004061
904 OVULATION 3 18 0.000795 0.004061
905 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 3 18 0.000795 0.004061
906 RESPONSE TO CAFFEINE 3 18 0.000795 0.004061
907 POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION 3 18 0.000795 0.004061
908 MAST CELL MEDIATED IMMUNITY 3 18 0.000795 0.004061
909 NOTOCHORD DEVELOPMENT 3 18 0.000795 0.004061
910 LYMPHOCYTE APOPTOTIC PROCESS 3 18 0.000795 0.004061
911 MUSCLE CELL MIGRATION 3 18 0.000795 0.004061
912 MYELOID CELL DIFFERENTIATION 8 189 0.000809 0.004128
913 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 6 106 0.0008262 0.004197
914 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 6 106 0.0008262 0.004197
915 REGULATION OF GLUCOSE METABOLIC PROCESS 6 106 0.0008262 0.004197
916 FAT CELL DIFFERENTIATION 6 106 0.0008262 0.004197
917 REGULATION OF MEMBRANE DEPOLARIZATION 4 41 0.0008364 0.00423
918 CELLULAR RESPONSE TO ESTROGEN STIMULUS 4 41 0.0008364 0.00423
919 MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 4 41 0.0008364 0.00423
920 MONOCYTE CHEMOTAXIS 4 41 0.0008364 0.00423
921 MUSCLE CELL DIFFERENTIATION 9 237 0.0008395 0.004241
922 SKIN EPIDERMIS DEVELOPMENT 5 71 0.0008467 0.004273
923 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 4 42 0.000917 0.004613
924 REGULATION OF BONE REMODELING 4 42 0.000917 0.004613
925 REGULATION OF HEART GROWTH 4 42 0.000917 0.004613
926 DEVELOPMENTAL MATURATION 8 193 0.0009266 0.004656
927 REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 3 19 0.0009369 0.004683
928 CELLULAR SODIUM ION HOMEOSTASIS 3 19 0.0009369 0.004683
929 CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 3 19 0.0009369 0.004683
930 MACROPHAGE DIFFERENTIATION 3 19 0.0009369 0.004683
931 ASTROCYTE DEVELOPMENT 3 19 0.0009369 0.004683
932 ASSOCIATIVE LEARNING 5 73 0.0009606 0.004786
933 PANCREAS DEVELOPMENT 5 73 0.0009606 0.004786
934 CELLULAR RESPONSE TO KETONE 5 73 0.0009606 0.004786
935 MULTI ORGANISM REPRODUCTIVE PROCESS 20 891 0.0009815 0.004885
936 RESPONSE TO ELECTRICAL STIMULUS 4 43 0.001003 0.004973
937 REGULATION OF SECRETION 17 699 0.001004 0.004973
938 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 4 43 0.001003 0.004973
939 REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY 4 43 0.001003 0.004973
940 CARDIAC MUSCLE CELL DIFFERENTIATION 5 74 0.001022 0.005057
941 POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 6 111 0.001051 0.005197
942 NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 9 245 0.00106 0.005236
943 SINGLE ORGANISM CELLULAR LOCALIZATION 20 898 0.001079 0.005324
944 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 5 75 0.001086 0.005345
945 POSITIVE REGULATION OF AUTOPHAGY 5 75 0.001086 0.005345
946 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 3 20 0.001094 0.005366
947 NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 3 20 0.001094 0.005366
948 REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 4 44 0.001094 0.005366
949 LYMPH VESSEL DEVELOPMENT 3 20 0.001094 0.005366
950 NEUROLOGICAL SYSTEM PROCESS 25 1242 0.001107 0.005421
951 ESTABLISHMENT OF LOCALIZATION IN CELL 31 1676 0.001115 0.005456
952 WNT SIGNALING PATHWAY 11 351 0.001122 0.005472
953 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 11 351 0.001122 0.005472
954 RESPONSE TO VIRUS 9 247 0.001122 0.005472
955 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 5 76 0.001152 0.0056
956 EXTRACELLULAR MATRIX DISASSEMBLY 5 76 0.001152 0.0056
957 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 6 113 0.001153 0.0056
958 PROTEIN HETEROOLIGOMERIZATION 6 113 0.001153 0.0056
959 PROTEIN IMPORT 7 155 0.001175 0.005703
960 LUNG MORPHOGENESIS 4 45 0.001192 0.005769
961 MODIFICATION BY SYMBIONT OF HOST MORPHOLOGY OR PHYSIOLOGY 4 45 0.001192 0.005769
962 SKELETAL SYSTEM MORPHOGENESIS 8 201 0.001203 0.005818
963 REGULATION OF EMBRYONIC DEVELOPMENT 6 114 0.001207 0.00583
964 NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS 7 156 0.00122 0.005876
965 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 7 156 0.00122 0.005876
966 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 7 156 0.00122 0.005876
967 B CELL HOMEOSTASIS 3 21 0.001267 0.006069
968 MAST CELL ACTIVATION 3 21 0.001267 0.006069
969 POSITIVE T CELL SELECTION 3 21 0.001267 0.006069
970 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 3 21 0.001267 0.006069
971 CELLULAR RESPONSE TO ALCOHOL 6 115 0.001262 0.006069
972 MACROMOLECULAR COMPLEX ASSEMBLY 27 1398 0.001283 0.006141
973 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 4 46 0.001295 0.006191
974 ACTIVATION OF INNATE IMMUNE RESPONSE 8 204 0.001322 0.006315
975 REGULATION OF SYNAPSE ASSEMBLY 5 79 0.001371 0.006544
976 THYMUS DEVELOPMENT 4 47 0.001404 0.006685
977 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 4 47 0.001404 0.006685
978 REGULATION OF PROTEIN TARGETING 10 307 0.001407 0.006693
979 NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 5 80 0.00145 0.006894
980 SINGLE ORGANISM BIOSYNTHETIC PROCESS 26 1340 0.001483 0.007043
981 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 4 48 0.001519 0.007197
982 DIGESTIVE TRACT MORPHOGENESIS 4 48 0.001519 0.007197
983 METANEPHROS DEVELOPMENT 5 81 0.001533 0.007249
984 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 5 81 0.001533 0.007249
985 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 8 209 0.001541 0.00728
986 REGULATION OF NUCLEAR DIVISION 7 163 0.001571 0.007398
987 CELLULAR RESPONSE TO BIOTIC STIMULUS 7 163 0.001571 0.007398
988 RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 7 163 0.001571 0.007398
989 POSITIVE REGULATION OF PROTEIN SECRETION 8 211 0.001636 0.007691
990 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 8 211 0.001636 0.007691
991 REGULATION OF B CELL ACTIVATION 6 121 0.001638 0.007693
992 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 3 23 0.001661 0.007729
993 RESPONSE TO MAGNESIUM ION 3 23 0.001661 0.007729
994 RESPONSE TO INCREASED OXYGEN LEVELS 3 23 0.001661 0.007729
995 LYSOSOME LOCALIZATION 3 23 0.001661 0.007729
996 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS 3 23 0.001661 0.007729
997 REGULATION OF OSTEOBLAST PROLIFERATION 3 23 0.001661 0.007729
998 REGULATION OF METANEPHROS DEVELOPMENT 3 23 0.001661 0.007729
999 RESPONSE TO HYPEROXIA 3 23 0.001661 0.007729
1000 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 3 23 0.001661 0.007729
1001 REGULATION OF TRANSMEMBRANE TRANSPORT 12 426 0.001676 0.00779
1002 REGULATION OF ERBB SIGNALING PATHWAY 5 83 0.001709 0.007887
1003 HAIR CYCLE 5 83 0.001709 0.007887
1004 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 6 122 0.001709 0.007887
1005 EMBRYONIC PLACENTA DEVELOPMENT 5 83 0.001709 0.007887
1006 MOLTING CYCLE 5 83 0.001709 0.007887
1007 RESPONSE TO FATTY ACID 5 83 0.001709 0.007887
1008 LOCALIZATION WITHIN MEMBRANE 6 122 0.001709 0.007887
1009 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 7 166 0.001743 0.008039
1010 LYMPHOCYTE HOMEOSTASIS 4 50 0.001769 0.008126
1011 RESPONSE TO GAMMA RADIATION 4 50 0.001769 0.008126
1012 VISUAL BEHAVIOR 4 50 0.001769 0.008126
1013 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 4 50 0.001769 0.008126
1014 AGING 9 264 0.001775 0.008146
1015 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 5 84 0.001802 0.00826
1016 PROTEIN LOCALIZATION 32 1805 0.001836 0.008408
1017 FOCAL ADHESION ASSEMBLY 3 24 0.001884 0.008569
1018 NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 3 24 0.001884 0.008569
1019 REGULATION OF MYELOID CELL APOPTOTIC PROCESS 3 24 0.001884 0.008569
1020 POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 3 24 0.001884 0.008569
1021 POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 3 24 0.001884 0.008569
1022 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 3 24 0.001884 0.008569
1023 CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY 3 24 0.001884 0.008569
1024 CELLULAR RESPONSE TO FATTY ACID 4 51 0.001904 0.008636
1025 HOMOTYPIC CELL CELL ADHESION 4 51 0.001904 0.008636
1026 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 4 51 0.001904 0.008636
1027 REGULATION OF BLOOD PRESSURE 7 169 0.00193 0.008727
1028 APPENDAGE DEVELOPMENT 7 169 0.00193 0.008727
1029 LIMB DEVELOPMENT 7 169 0.00193 0.008727
1030 REGULATION OF CELL CYCLE PHASE TRANSITION 10 321 0.001953 0.008825
1031 NEGATIVE REGULATION OF CELL GROWTH 7 170 0.001996 0.009006
1032 POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 4 52 0.002046 0.009227
1033 CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS 3 25 0.002125 0.009542
1034 DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION 3 25 0.002125 0.009542
1035 POSITIVE REGULATION OF COAGULATION 3 25 0.002125 0.009542
1036 EPITHELIAL CELL APOPTOTIC PROCESS 3 25 0.002125 0.009542
1037 REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 6 128 0.002179 0.009775
1038 INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 4 53 0.002196 0.009843
1039 MYELOID CELL HOMEOSTASIS 5 88 0.002212 0.009905
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR BINDING 81 1476 2.542e-38 2.362e-35
2 KINASE ACTIVITY 62 842 8.468e-36 3.933e-33
3 PROTEIN KINASE ACTIVITY 52 640 7.371e-32 2.283e-29
4 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 62 992 1.021e-31 2.371e-29
5 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 24 70 1.351e-30 2.511e-28
6 MOLECULAR FUNCTION REGULATOR 65 1353 9.711e-27 1.504e-24
7 PROTEIN TYROSINE KINASE ACTIVITY 29 176 1.279e-26 1.697e-24
8 GROWTH FACTOR ACTIVITY 28 160 1.726e-26 2.005e-24
9 GROWTH FACTOR BINDING 25 123 1.856e-25 1.915e-23
10 GROWTH FACTOR RECEPTOR BINDING 23 129 4.112e-22 3.82e-20
11 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 16 43 2e-21 1.689e-19
12 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 16 51 5.032e-20 3.896e-18
13 PROTEIN COMPLEX BINDING 47 935 7.375e-20 5.27e-18
14 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 17 64 8.302e-20 5.509e-18
15 ENZYME BINDING 63 1737 2.035e-19 1.26e-17
16 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 17 81 6.631e-18 3.85e-16
17 KINASE BINDING 36 606 1.542e-17 8.424e-16
18 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 24 228 1.698e-17 8.764e-16
19 SIGNAL TRANSDUCER ACTIVITY 59 1731 7.533e-17 3.683e-15
20 MACROMOLECULAR COMPLEX BINDING 52 1399 2.492e-16 1.158e-14
21 CELL ADHESION MOLECULE BINDING 21 186 4.606e-16 2.037e-14
22 INTEGRIN BINDING 17 105 6.812e-16 2.877e-14
23 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 9 15 5.429e-15 2.193e-13
24 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 24 303 1.103e-14 4.27e-13
25 COLLAGEN BINDING 13 65 1.096e-13 4.073e-12
26 HEPARIN BINDING 17 157 6.363e-13 2.274e-11
27 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 13 76 9.227e-13 3.175e-11
28 ENZYME REGULATOR ACTIVITY 37 959 3.651e-12 1.173e-10
29 PLATELET DERIVED GROWTH FACTOR BINDING 7 11 3.662e-12 1.173e-10
30 KINASE REGULATOR ACTIVITY 17 186 1.009e-11 3.125e-10
31 PROTEIN PHOSPHATASE TYPE 2A REGULATOR ACTIVITY 8 21 2.085e-11 6.247e-10
32 PROTEIN PHOSPHATASE BINDING 14 120 2.659e-11 7.72e-10
33 SULFUR COMPOUND BINDING 18 234 4.403e-11 1.24e-09
34 GLYCOSAMINOGLYCAN BINDING 17 205 4.771e-11 1.304e-09
35 INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING 7 15 6.895e-11 1.83e-09
36 EXTRACELLULAR MATRIX BINDING 10 51 1.002e-10 2.585e-09
37 PHOSPHATASE BINDING 15 162 1.441e-10 3.618e-09
38 PROTEIN SERINE THREONINE KINASE ACTIVITY 23 445 2.577e-10 6.299e-09
39 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 8 28 2.992e-10 6.95e-09
40 FIBRONECTIN BINDING 8 28 2.992e-10 6.95e-09
41 RECEPTOR ACTIVITY 46 1649 4.066e-10 9.212e-09
42 CYTOKINE RECEPTOR BINDING 18 271 4.861e-10 1.075e-08
43 INSULIN RECEPTOR SUBSTRATE BINDING 6 11 5.059e-10 1.093e-08
44 IDENTICAL PROTEIN BINDING 38 1209 7.054e-10 1.489e-08
45 ADENYL NUCLEOTIDE BINDING 43 1514 1.002e-09 2.069e-08
46 CYTOKINE BINDING 11 92 2.892e-09 5.84e-08
47 SIGNALING RECEPTOR ACTIVITY 40 1393 3.182e-09 6.201e-08
48 NEUROTROPHIN RECEPTOR BINDING 6 14 3.204e-09 6.201e-08
49 RIBONUCLEOTIDE BINDING 47 1860 6.217e-09 1.179e-07
50 CHEMOATTRACTANT ACTIVITY 7 27 8.563e-09 1.591e-07
51 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 7 30 1.912e-08 3.483e-07
52 CYTOKINE RECEPTOR ACTIVITY 10 89 2.834e-08 5.063e-07
53 PROTEIN DIMERIZATION ACTIVITY 33 1149 9.421e-08 1.651e-06
54 LAMININ BINDING 6 30 5.518e-07 9.493e-06
55 PROTEIN DOMAIN SPECIFIC BINDING 22 624 5.837e-07 9.859e-06
56 PROTEIN BINDING INVOLVED IN CELL ADHESION 5 17 6.329e-07 1.031e-05
57 VIRUS RECEPTOR ACTIVITY 8 70 6.264e-07 1.031e-05
58 INSULIN RECEPTOR BINDING 6 32 8.277e-07 1.303e-05
59 SODIUM CHANNEL REGULATOR ACTIVITY 6 32 8.277e-07 1.303e-05
60 HISTONE KINASE ACTIVITY 5 19 1.169e-06 1.811e-05
61 PROTEIN TYROSINE KINASE BINDING 7 54 1.348e-06 2.053e-05
62 PROTEIN HETERODIMERIZATION ACTIVITY 18 468 1.949e-06 2.92e-05
63 PHOSPHATASE REGULATOR ACTIVITY 8 87 3.336e-06 4.92e-05
64 KINASE ACTIVATOR ACTIVITY 7 62 3.49e-06 5.066e-05
65 EPHRIN RECEPTOR BINDING 5 24 4.098e-06 5.857e-05
66 PROTEIN HOMODIMERIZATION ACTIVITY 22 722 6.27e-06 8.825e-05
67 CAMP RESPONSE ELEMENT BINDING 4 13 7.408e-06 0.0001027
68 CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY 5 28 9.162e-06 0.0001252
69 PROTEASE BINDING 8 104 1.266e-05 0.0001682
70 RECEPTOR SIGNALING PROTEIN ACTIVITY 10 172 1.267e-05 0.0001682
71 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE ACTIVITY 4 16 1.84e-05 0.0002408
72 PEPTIDE HORMONE BINDING 5 36 3.286e-05 0.000424
73 PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY 5 39 4.893e-05 0.0006227
74 CHEMOKINE BINDING 4 21 5.811e-05 0.0007295
75 FIBROBLAST GROWTH FACTOR BINDING 4 23 8.459e-05 0.001048
76 PROTEIN PHOSPHATASE 2A BINDING 4 28 0.0001878 0.002296
77 TAU PROTEIN BINDING 3 12 0.0002244 0.002707
78 ENZYME ACTIVATOR ACTIVITY 14 471 0.0004141 0.004932
79 CHANNEL REGULATOR ACTIVITY 7 131 0.0004343 0.005108
80 CYTOKINE ACTIVITY 9 219 0.0004773 0.005542
81 CHLORIDE CHANNEL REGULATOR ACTIVITY 3 16 0.000554 0.006354
82 HORMONE BINDING 5 65 0.0005647 0.006398
83 CORECEPTOR ACTIVITY 4 38 0.0006246 0.006991
NumGOOverlapSizeP ValueAdj. P Value
1 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 19 30 4.094e-31 2.391e-28
2 RECEPTOR COMPLEX 35 327 2.06e-25 6.015e-23
3 CELL SURFACE 47 757 1.166e-23 2.27e-21
4 PLASMA MEMBRANE RECEPTOR COMPLEX 26 175 9.542e-23 1.393e-20
5 EXTRACELLULAR MATRIX 36 426 1.396e-22 1.631e-20
6 EXTRACELLULAR MATRIX COMPONENT 23 125 1.923e-22 1.872e-20
7 PROTEINACEOUS EXTRACELLULAR MATRIX 32 356 6.091e-21 5.081e-19
8 BASEMENT MEMBRANE 19 93 1.223e-19 8.928e-18
9 SIDE OF MEMBRANE 31 428 1.355e-17 8.794e-16
10 COMPLEX OF COLLAGEN TRIMERS 11 23 1.355e-16 7.461e-15
11 CELL SUBSTRATE JUNCTION 29 398 1.405e-16 7.461e-15
12 PLASMA MEMBRANE PROTEIN COMPLEX 32 510 2.471e-16 1.202e-14
13 INTRINSIC COMPONENT OF PLASMA MEMBRANE 55 1649 2.928e-15 1.315e-13
14 MEMBRANE PROTEIN COMPLEX 42 1020 1.065e-14 4.442e-13
15 TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 21 237 6.13e-14 2.387e-12
16 EXTRACELLULAR SPACE 47 1376 2.146e-13 7.371e-12
17 ANCHORING JUNCTION 28 489 2.066e-13 7.371e-12
18 BASAL LAMINA 9 21 3.022e-13 9.804e-12
19 MEMBRANE REGION 41 1134 1.65e-12 5.073e-11
20 EXTRINSIC COMPONENT OF MEMBRANE 20 252 1.959e-12 5.719e-11
21 INTRACELLULAR VESICLE 43 1259 2.826e-12 7.859e-11
22 EXTERNAL SIDE OF PLASMA MEMBRANE 19 238 6.47e-12 1.652e-10
23 COLLAGEN TRIMER 13 88 6.507e-12 1.652e-10
24 PROTEIN KINASE COMPLEX 13 90 8.747e-12 2.128e-10
25 PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX 8 20 1.302e-11 2.925e-10
26 PROTEIN PHOSPHATASE TYPE 2A COMPLEX 8 20 1.302e-11 2.925e-10
27 CELL JUNCTION 39 1151 4.471e-11 9.671e-10
28 PLASMA MEMBRANE REGION 34 929 1.272e-10 2.652e-09
29 CATALYTIC COMPLEX 36 1038 1.491e-10 3.002e-09
30 PLATELET ALPHA GRANULE 11 75 3.072e-10 5.98e-09
31 VESICLE LUMEN 12 106 1.031e-09 1.941e-08
32 MEMBRANE MICRODOMAIN 18 288 1.29e-09 2.355e-08
33 ENDOPLASMIC RETICULUM LUMEN 15 201 2.939e-09 5.201e-08
34 PLATELET ALPHA GRANULE LUMEN 9 55 4.823e-09 8.284e-08
35 CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX 7 31 2.448e-08 4.085e-07
36 CYTOPLASMIC SIDE OF MEMBRANE 13 170 2.564e-08 4.159e-07
37 PHOSPHATASE COMPLEX 8 48 3.042e-08 4.802e-07
38 PERINUCLEAR REGION OF CYTOPLASM 24 642 5.851e-08 8.992e-07
39 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 10 98 7.2e-08 1.078e-06
40 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 11 136 1.762e-07 2.573e-06
41 SECRETORY GRANULE LUMEN 9 85 2.389e-07 3.403e-06
42 CYTOPLASMIC VESICLE PART 21 601 1.234e-06 1.717e-05
43 PLASMA MEMBRANE RAFT 8 86 3.056e-06 4.151e-05
44 CELL LEADING EDGE 15 350 3.939e-06 5.228e-05
45 TRANSFERASE COMPLEX 22 703 4.105e-06 5.327e-05
46 SECRETORY GRANULE 15 352 4.221e-06 5.359e-05
47 BANDED COLLAGEN FIBRIL 4 12 5.171e-06 6.425e-05
48 LEADING EDGE MEMBRANE 9 134 1.094e-05 0.0001331
49 HETEROTRIMERIC G PROTEIN COMPLEX 5 32 1.815e-05 0.0002163
50 RUFFLE MEMBRANE 7 80 1.927e-05 0.000225
51 SECRETORY VESICLE 16 461 2.614e-05 0.0002994
52 ENDOPLASMIC RETICULUM 35 1631 2.827e-05 0.0003175
53 SYNAPSE 21 754 3.884e-05 0.000428
54 LAMELLIPODIUM 9 172 7.855e-05 0.0008364
55 CELL PROJECTION 36 1786 7.877e-05 0.0008364
56 NEURON PART 28 1265 0.0001172 0.001222
57 SOMATODENDRITIC COMPARTMENT 18 650 0.0001519 0.001556
58 BASAL PART OF CELL 5 51 0.0001805 0.001818
59 VACUOLE 26 1180 0.0002247 0.002194
60 RUFFLE 8 156 0.0002254 0.002194
61 NEUROMUSCULAR JUNCTION 5 54 0.000237 0.002269
62 CELL PROJECTION MEMBRANE 11 298 0.0002892 0.002724
63 CELL PROJECTION PART 22 946 0.0003391 0.003144
64 BASOLATERAL PLASMA MEMBRANE 9 211 0.0003641 0.003322
65 ENDOSOME 19 793 0.0006092 0.005474
66 PIGMENT GRANULE 6 103 0.0007105 0.006286
67 FILOPODIUM MEMBRANE 3 18 0.000795 0.006869
68 NEURON PROJECTION 21 942 0.0007999 0.006869
69 PERIKARYON 6 108 0.0009111 0.007712
70 LAMELLIPODIUM MEMBRANE 3 19 0.0009369 0.007817
71 ENDOPLASMIC RETICULUM PART 24 1163 0.000996 0.008192
72 EXCITATORY SYNAPSE 8 197 0.001058 0.008578
73 VACUOLAR LUMEN 6 115 0.001262 0.009995
74 MAST CELL GRANULE 3 21 0.001267 0.009995

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04151_PI3K_AKT_signaling_pathway 207 351 0 0
2 hsa04510_Focal_adhesion 85 200 1.724e-120 1.551e-118
3 hsa04014_Ras_signaling_pathway 75 236 7.292e-94 4.375e-92
4 hsa04512_ECM.receptor_interaction 47 85 2.846e-72 1.281e-70
5 hsa04810_Regulation_of_actin_cytoskeleton 57 214 2.15e-65 7.74e-64
6 hsa04722_Neurotrophin_signaling_pathway 30 127 1.61e-32 4.406e-31
7 hsa04150_mTOR_signaling_pathway 23 52 1.713e-32 4.406e-31
8 hsa04010_MAPK_signaling_pathway 36 268 1.182e-29 2.65e-28
9 hsa04012_ErbB_signaling_pathway 25 87 1.325e-29 2.65e-28
10 hsa04630_Jak.STAT_signaling_pathway 29 155 2.705e-28 4.869e-27
11 hsa04062_Chemokine_signaling_pathway 29 189 1.077e-25 1.763e-24
12 hsa04910_Insulin_signaling_pathway 26 138 1.569e-25 2.353e-24
13 hsa04662_B_cell_receptor_signaling_pathway 20 75 3.819e-23 5.288e-22
14 hsa04640_Hematopoietic_cell_lineage 19 88 3.965e-20 5.098e-19
15 hsa04370_VEGF_signaling_pathway 18 76 6.499e-20 7.799e-19
16 hsa04960_Aldosterone.regulated_sodium_reabsorption 15 42 7.742e-20 8.71e-19
17 hsa04664_Fc_epsilon_RI_signaling_pathway 17 79 4.201e-18 4.448e-17
18 hsa04380_Osteoclast_differentiation 19 128 6.817e-17 6.817e-16
19 hsa04620_Toll.like_receptor_signaling_pathway 17 102 4.097e-16 3.882e-15
20 hsa04660_T_cell_receptor_signaling_pathway 17 108 1.114e-15 1.003e-14
21 hsa04650_Natural_killer_cell_mediated_cytotoxicity 18 136 3.684e-15 3.158e-14
22 hsa04914_Progesterone.mediated_oocyte_maturation 15 87 1.374e-14 1.124e-13
23 hsa04110_Cell_cycle 17 128 2.076e-14 1.625e-13
24 hsa04114_Oocyte_meiosis 16 114 5.116e-14 3.837e-13
25 hsa04666_Fc_gamma_R.mediated_phagocytosis 15 95 5.36e-14 3.859e-13
26 hsa04210_Apoptosis 14 89 4.015e-13 2.779e-12
27 hsa04540_Gap_junction 14 90 4.711e-13 3.141e-12
28 hsa04115_p53_signaling_pathway 12 69 5.767e-12 3.707e-11
29 hsa04390_Hippo_signaling_pathway 15 154 6.993e-11 4.341e-10
30 hsa04974_Protein_digestion_and_absorption 11 81 7.203e-10 4.322e-09
31 hsa04360_Axon_guidance 13 130 9.694e-10 5.629e-09
32 hsa04350_TGF.beta_signaling_pathway 11 85 1.223e-09 6.877e-09
33 hsa04670_Leukocyte_transendothelial_migration 12 117 3.249e-09 1.772e-08
34 hsa04973_Carbohydrate_digestion_and_absorption 8 44 1.481e-08 7.838e-08
35 hsa04144_Endocytosis 14 203 2.741e-08 1.41e-07
36 hsa04730_Long.term_depression 9 70 4.315e-08 2.157e-07
37 hsa04310_Wnt_signaling_pathway 12 151 5.841e-08 2.842e-07
38 hsa04145_Phagosome 12 156 8.376e-08 3.968e-07
39 hsa04916_Melanogenesis 10 101 9.615e-08 4.438e-07
40 hsa04070_Phosphatidylinositol_signaling_system 9 78 1.126e-07 5.069e-07
41 hsa04320_Dorso.ventral_axis_formation 6 25 1.718e-07 7.544e-07
42 hsa03015_mRNA_surveillance_pathway 9 83 1.942e-07 8.322e-07
43 hsa04920_Adipocytokine_signaling_pathway 8 68 4.993e-07 2.09e-06
44 hsa04530_Tight_junction 10 133 1.267e-06 5.185e-06
45 hsa04912_GnRH_signaling_pathway 8 101 1.02e-05 4.079e-05
46 hsa04520_Adherens_junction 7 73 1.05e-05 4.11e-05
47 hsa04514_Cell_adhesion_molecules_.CAMs. 8 136 8.723e-05 0.0003341
48 hsa00562_Inositol_phosphate_metabolism 5 57 0.000306 0.001148
49 hsa04621_NOD.like_receptor_signaling_pathway 5 59 0.0003599 0.001322
50 hsa04720_Long.term_potentiation 5 70 0.0007936 0.002857
51 hsa04020_Calcium_signaling_pathway 7 177 0.002504 0.008839
52 hsa04962_Vasopressin.regulated_water_reabsorption 3 44 0.0106 0.03668
53 hsa04672_Intestinal_immune_network_for_IgA_production 3 49 0.0142 0.04822
54 hsa04623_Cytosolic_DNA.sensing_pathway 3 56 0.02027 0.06756
55 hsa04140_Regulation_of_autophagy 2 34 0.04816 0.1576
56 hsa04270_Vascular_smooth_muscle_contraction 3 116 0.1192 0.3832
57 hsa04610_Complement_and_coagulation_cascades 2 69 0.16 0.5054
58 hsa04622_RIG.I.like_receptor_signaling_pathway 2 71 0.1673 0.5193
59 hsa04141_Protein_processing_in_endoplasmic_reticulum 3 168 0.2524 0.77
60 hsa04972_Pancreatic_secretion 2 101 0.281 0.8431
61 hsa03013_RNA_transport 2 152 0.468 1

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1

MAGI2-AS3

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-30d-3p;hsa-miR-31-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-501-5p;hsa-miR-590-3p;hsa-miR-616-5p 17 FGF7 Sponge network -4.563 0 -5.509 0 0.773
2

MAGI2-AS3

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-2110;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-93-5p 32 PDGFRA Sponge network -4.563 0 -4.316 1.0E-5 0.763
3

MEG3

 hsa-let-7d-5p;hsa-let-7f-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-330-3p;hsa-miR-92a-1-5p;hsa-miR-93-5p 11 COL1A1 Sponge network -3.613 0.00075 -1.841 0.04283 0.709
4

MAGI2-AS3

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7g-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-30d-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-7-5p;hsa-miR-92a-3p;hsa-miR-92b-3p 17 COL1A2 Sponge network -4.563 0 -2.407 0.0132 0.707
5

RP11-166D19.1

 hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-944;hsa-miR-96-5p 29 PDGFRA Sponge network -4.209 2.0E-5 -4.316 1.0E-5 0.697
6

MAGI2-AS3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-93-5p 13 THBS2 Sponge network -4.563 0 -2.628 0.00636 0.694
7

MAGI2-AS3

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-23a-5p;hsa-miR-30d-3p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-92a-1-5p;hsa-miR-93-5p 15 COL1A1 Sponge network -4.563 0 -1.841 0.04283 0.694
8

MIR143HG

 hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-2110;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-301a-3p;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-93-5p 30 PDGFRA Sponge network -6.51 0 -4.316 1.0E-5 0.692
9

MAGI2-AS3

 hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-183-5p;hsa-miR-19b-1-5p;hsa-miR-301a-3p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-454-3p 11 ITGA8 Sponge network -4.563 0 -4.419 0.00157 0.691
10

MEG3

 hsa-let-7f-1-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-2110;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-330-5p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-93-5p;hsa-miR-944;hsa-miR-96-5p 21 PDGFRA Sponge network -3.613 0.00075 -4.316 1.0E-5 0.69
11

HAND2-AS1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-2110;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-421;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-944 29 PDGFRA Sponge network -7.871 0 -4.316 1.0E-5 0.672
12

DNM3OS

 hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-2110;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-93-5p;hsa-miR-96-5p 30 PDGFRA Sponge network -3.933 0.00059 -4.316 1.0E-5 0.671
13

DNM3OS

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p 17 FGF7 Sponge network -3.933 0.00059 -5.509 0 0.667
14

MAGI2-AS3

 hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-3065-5p;hsa-miR-33a-3p;hsa-miR-500a-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p 13 THBS1 Sponge network -4.563 0 -3.751 0.0001 0.664
15

MIR143HG

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-30d-3p;hsa-miR-31-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p 17 FGF7 Sponge network -6.51 0 -5.509 0 0.658
16

MAGI2-AS3

 hsa-miR-130a-5p;hsa-miR-149-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-429;hsa-miR-590-3p 10 KDR Sponge network -4.563 0 -3.788 0 0.657
17

MIR143HG

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7g-5p;hsa-miR-193a-3p;hsa-miR-196a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-30d-3p;hsa-miR-32-5p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-7-5p;hsa-miR-92a-3p;hsa-miR-92b-3p 17 COL1A2 Sponge network -6.51 0 -2.407 0.0132 0.654
18

HAND2-AS1

 hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-486-5p;hsa-miR-629-5p;hsa-miR-940 15 IGF1 Sponge network -7.871 0 -4.485 0.00149 0.653
19

DNM3OS

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-196a-5p;hsa-miR-20a-5p;hsa-miR-23a-5p;hsa-miR-30d-3p;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-93-5p 14 COL1A1 Sponge network -3.933 0.00059 -1.841 0.04283 0.646
20

RP11-166D19.1

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-452-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-616-5p 17 FGF7 Sponge network -4.209 2.0E-5 -5.509 0 0.645
21

HAND2-AS1

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-486-5p;hsa-miR-590-3p 15 FGF7 Sponge network -7.871 0 -5.509 0 0.642
22

RP11-166D19.1

 hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p 11 THBS1 Sponge network -4.209 2.0E-5 -3.751 0.0001 0.639
23

RP11-554A11.4

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-2110;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-339-5p;hsa-miR-421 14 PDGFRA Sponge network -5.361 2.0E-5 -4.316 1.0E-5 0.638
24

DNM3OS

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7g-5p;hsa-miR-193a-3p;hsa-miR-196a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-7-5p 12 COL1A2 Sponge network -3.933 0.00059 -2.407 0.0132 0.638
25

MAGI2-AS3

 hsa-let-7f-2-3p;hsa-miR-141-5p;hsa-miR-200b-3p;hsa-miR-20a-3p;hsa-miR-3065-5p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-452-3p;hsa-miR-590-3p 11 ITGA9 Sponge network -4.563 0 -4.473 0 0.634
26

RP11-389C8.2

 hsa-miR-130a-5p;hsa-miR-149-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-3065-3p;hsa-miR-429 10 KDR Sponge network -3.089 2.0E-5 -3.788 0 0.633
27

MIR143HG

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-196a-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-23a-5p;hsa-miR-30d-3p;hsa-miR-330-3p;hsa-miR-361-3p;hsa-miR-590-3p;hsa-miR-616-5p;hsa-miR-625-5p;hsa-miR-92a-1-5p;hsa-miR-93-5p 18 COL1A1 Sponge network -6.51 0 -1.841 0.04283 0.631
28

EMX2OS

 hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-32-3p;hsa-miR-452-5p;hsa-miR-486-5p;hsa-miR-629-5p;hsa-miR-940 14 IGF1 Sponge network -6.205 0.00015 -4.485 0.00149 0.631
29

MIR143HG

 hsa-miR-141-5p;hsa-miR-200b-3p;hsa-miR-20a-3p;hsa-miR-3065-5p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-590-3p 10 ITGA9 Sponge network -6.51 0 -4.473 0 0.624
30

DNM3OS

 hsa-miR-141-5p;hsa-miR-200b-3p;hsa-miR-20a-3p;hsa-miR-3065-5p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-590-3p 10 ITGA9 Sponge network -3.933 0.00059 -4.473 0 0.608
31

MIR143HG

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 12 THBS2 Sponge network -6.51 0 -2.628 0.00636 0.606
32

RP11-161M6.2

 hsa-miR-1271-5p;hsa-miR-17-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-330-5p;hsa-miR-3615;hsa-miR-940 10 GNG7 Sponge network -2.608 0.00296 -4.495 0 0.605
33

ADAMTS9-AS1

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 15 FGF7 Sponge network -8.573 0.00012 -5.509 0 0.603
34

MIR143HG

 hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-3065-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p 12 THBS1 Sponge network -6.51 0 -3.751 0.0001 0.603
35

DNM3OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 10 THBS2 Sponge network -3.933 0.00059 -2.628 0.00636 0.597
36

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-421;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-944 19 PDGFRA Sponge network -6.205 0.00015 -4.316 1.0E-5 0.593
37

MEG3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-3614-5p;hsa-miR-93-5p;hsa-miR-96-5p 10 THBS2 Sponge network -3.613 0.00075 -2.628 0.00636 0.586
38

DNM3OS

 hsa-miR-149-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-3065-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 11 KDR Sponge network -3.933 0.00059 -3.788 0 0.586
39

RP11-166D19.1

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-23a-5p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-616-5p 12 COL1A1 Sponge network -4.209 2.0E-5 -1.841 0.04283 0.586
40

RP11-166D19.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-96-5p 12 THBS2 Sponge network -4.209 2.0E-5 -2.628 0.00636 0.584
41

DNM3OS

 hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-3065-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-616-5p 13 THBS1 Sponge network -3.933 0.00059 -3.751 0.0001 0.584
42

RP11-389C8.2

 hsa-miR-1271-5p;hsa-miR-130a-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-200a-3p;hsa-miR-23a-3p;hsa-miR-31-5p 13 GNG7 Sponge network -3.089 2.0E-5 -4.495 0 0.582
43

MAGI2-AS3

 hsa-miR-130a-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-1976;hsa-miR-200a-3p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-31-5p;hsa-miR-330-5p;hsa-miR-3615;hsa-miR-616-5p;hsa-miR-92a-3p;hsa-miR-940 17 GNG7 Sponge network -4.563 0 -4.495 0 0.578
44

RP11-389C8.2

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-2110;hsa-miR-219a-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-421;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-589-3p;hsa-miR-93-5p 23 PDGFRA Sponge network -3.089 2.0E-5 -4.316 1.0E-5 0.578
45

RP11-389C8.2

 hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p 10 IGF1 Sponge network -3.089 2.0E-5 -4.485 0.00149 0.575
46

RP11-166D19.1

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7g-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-33a-3p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-92a-3p 12 COL1A2 Sponge network -4.209 2.0E-5 -2.407 0.0132 0.573
47

RP11-166D19.1

 hsa-miR-141-5p;hsa-miR-200b-3p;hsa-miR-20a-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-452-3p;hsa-miR-452-5p;hsa-miR-590-3p 10 ITGA9 Sponge network -4.209 2.0E-5 -4.473 0 0.572
48

MAGI2-AS3

 hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-629-5p;hsa-miR-940 16 IGF1 Sponge network -4.563 0 -4.485 0.00149 0.572
49

MEG3

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-31-5p;hsa-miR-33a-3p;hsa-miR-429 12 FGF7 Sponge network -3.613 0.00075 -5.509 0 0.571
50

HAND2-AS1

 hsa-let-7f-2-3p;hsa-miR-141-5p;hsa-miR-200b-3p;hsa-miR-20a-3p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-452-3p;hsa-miR-590-3p 11 ITGA9 Sponge network -7.871 0 -4.473 0 0.568
51

RP11-887P2.5

 hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-27a-3p;hsa-miR-486-5p;hsa-miR-576-5p;hsa-miR-940 11 IGF1 Sponge network -9.865 1.0E-5 -4.485 0.00149 0.567
52

MIR143HG

 hsa-miR-130a-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-3065-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 11 KDR Sponge network -6.51 0 -3.788 0 0.565
53

RP11-389C8.2

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-33a-3p;hsa-miR-429 13 FGF7 Sponge network -3.089 2.0E-5 -5.509 0 0.564
54

AC003090.1

 hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-576-5p 11 IGF1 Sponge network -7.817 0.00161 -4.485 0.00149 0.561
55

AC003090.1

 hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 12 FGF7 Sponge network -7.817 0.00161 -5.509 0 0.547
56

WT1-AS

 hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-2110;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-339-5p;hsa-miR-421;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-944;hsa-miR-96-5p 26 PDGFRA Sponge network -6.875 2.0E-5 -4.316 1.0E-5 0.546
57

MEG3

 hsa-let-7a-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-576-5p 10 THBS1 Sponge network -3.613 0.00075 -3.751 0.0001 0.544
58

TPTEP1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-2110;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-33b-5p;hsa-miR-590-3p 15 PDGFRA Sponge network -4.398 5.0E-5 -4.316 1.0E-5 0.542
59

AC003090.1

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p;hsa-miR-96-5p 20 PDGFRA Sponge network -7.817 0.00161 -4.316 1.0E-5 0.529
60

RP11-887P2.5

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-486-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 12 FGF7 Sponge network -9.865 1.0E-5 -5.509 0 0.528
61

MAGI2-AS3

 hsa-miR-141-5p;hsa-miR-200a-5p;hsa-miR-200b-3p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-3065-5p;hsa-miR-3607-3p;hsa-miR-362-3p;hsa-miR-429;hsa-miR-590-3p 10 ITGA1 Sponge network -4.563 0 -1.265 0.08839 0.521
62

MIR497HG

 hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-940 13 IGF1 Sponge network -6.146 0.00024 -4.485 0.00149 0.518
63

MIR143HG

 hsa-miR-130a-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-1976;hsa-miR-200a-3p;hsa-miR-224-5p;hsa-miR-31-3p;hsa-miR-31-5p;hsa-miR-3127-5p;hsa-miR-330-5p;hsa-miR-3615;hsa-miR-616-5p;hsa-miR-92a-3p;hsa-miR-940 18 GNG7 Sponge network -6.51 0 -4.495 0 0.514
64

EMX2OS

 hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-5p;hsa-miR-330-5p;hsa-miR-590-3p;hsa-miR-944 10 FGF9 Sponge network -6.205 0.00015 -4.087 0.01073 0.507
65 RP11-401P9.4 hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-20b-5p;hsa-miR-2110;hsa-miR-224-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-454-3p;hsa-miR-550a-5p 15 PDGFRA Sponge network -3.793 0.00144 -4.316 1.0E-5 0.506
66

RP11-344E13.3

 hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-486-5p;hsa-miR-590-3p;hsa-miR-590-5p 12 FGF7 Sponge network -4.307 3.0E-5 -5.509 0 0.506
67

CTD-2554C21.2

 hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-339-5p;hsa-miR-93-5p;hsa-miR-944 14 PDGFRA Sponge network -6.968 0.00817 -4.316 1.0E-5 0.502
68 RP11-822E23.8 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-589-3p;hsa-miR-93-5p 16 PDGFRA Sponge network -8.351 0.00374 -4.316 1.0E-5 0.501
69

ADAMTS9-AS1

 hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-576-5p;hsa-miR-629-5p;hsa-miR-940 14 IGF1 Sponge network -8.573 0.00012 -4.485 0.00149 0.499
70

ACTA2-AS1

 hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-484;hsa-miR-590-3p 12 FGF7 Sponge network -6.142 0.00223 -5.509 0 0.495
71

NR2F2-AS1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-590-3p 10 INSR Sponge network -3.785 0.00281 -1.824 0.00037 0.493
72

NR2F2-AS1

 hsa-miR-1271-5p;hsa-miR-16-2-3p;hsa-miR-18a-3p;hsa-miR-1976;hsa-miR-24-3p;hsa-miR-25-3p;hsa-miR-9-3p;hsa-miR-92a-1-5p;hsa-miR-92a-3p;hsa-miR-944 10 CREB3L2 Sponge network -3.785 0.00281 -2.05 0.00075 0.493
73

WT1-AS

 hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-629-5p;hsa-miR-940 16 IGF1 Sponge network -6.875 2.0E-5 -4.485 0.00149 0.493
74

MIR143HG

 hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-629-5p;hsa-miR-940 14 IGF1 Sponge network -6.51 0 -4.485 0.00149 0.49
75

WT1-AS

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-501-5p;hsa-miR-590-3p 15 FGF7 Sponge network -6.875 2.0E-5 -5.509 0 0.49
76 RP11-999E24.3 hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-2110;hsa-miR-27a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p 13 PDGFRA Sponge network -4.893 2.0E-5 -4.316 1.0E-5 0.487
77

MIR497HG

 hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-33a-3p;hsa-miR-501-5p;hsa-miR-590-5p;hsa-miR-7-1-3p 14 FGF7 Sponge network -6.146 0.00024 -5.509 0 0.487
78

RP11-344E13.3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 11 THBS2 Sponge network -4.307 3.0E-5 -2.628 0.00636 0.485
79 RP11-384L8.1 hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-205-5p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-590-3p 10 INSR Sponge network -1.784 0.21615 -1.824 0.00037 0.485
80

RP11-130L8.1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-2110;hsa-miR-219a-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-944 16 PDGFRA Sponge network -4.329 1.0E-5 -4.316 1.0E-5 0.484
81

RP11-13K12.1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-944 11 PDGFRA Sponge network -5.093 0.01151 -4.316 1.0E-5 0.484
82

DNM3OS

 hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-940 14 IGF1 Sponge network -3.933 0.00059 -4.485 0.00149 0.483
83

NR2F1-AS1

 hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-224-5p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-454-3p;hsa-miR-590-3p 12 PDGFRA Sponge network -2.961 0.00154 -4.316 1.0E-5 0.481
84

EMX2OS

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-22-5p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-3614-5p;hsa-miR-421;hsa-miR-944 13 PRLR Sponge network -6.205 0.00015 -5.28 0.00088 0.479
85

HAND2-AS1

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-22-5p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-3614-5p;hsa-miR-421;hsa-miR-944 14 PRLR Sponge network -7.871 0 -5.28 0.00088 0.478
86

RP11-166D19.1

 hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-452-5p;hsa-miR-576-5p 12 IGF1 Sponge network -4.209 2.0E-5 -4.485 0.00149 0.477
87

MEG3

 hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-1976;hsa-miR-224-5p;hsa-miR-31-3p;hsa-miR-31-5p;hsa-miR-330-5p;hsa-miR-3615;hsa-miR-96-5p 13 GNG7 Sponge network -3.613 0.00075 -4.495 0 0.476
88 CTD-2334D19.1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-590-3p;hsa-miR-93-5p 11 PDGFRA Sponge network -4.489 0.03789 -4.316 1.0E-5 0.472
89

AC003090.1

 hsa-miR-130a-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-31-5p;hsa-miR-96-5p 12 GNG7 Sponge network -7.817 0.00161 -4.495 0 0.472
90

HAND2-AS1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-421;hsa-miR-590-3p;hsa-miR-671-5p 11 KIT Sponge network -7.871 0 -2.927 0.01211 0.47
91

ADAMTS9-AS1

 hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-2110;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-339-5p;hsa-miR-421;hsa-miR-429;hsa-miR-454-3p;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p;hsa-miR-96-5p 32 PDGFRA Sponge network -8.573 0.00012 -4.316 1.0E-5 0.469
92

EMX2OS

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-452-5p;hsa-miR-484;hsa-miR-486-5p;hsa-miR-590-3p 15 FGF7 Sponge network -6.205 0.00015 -5.509 0 0.468
93

HAND2-AS1

 hsa-miR-130a-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-200a-3p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-31-3p;hsa-miR-31-5p;hsa-miR-330-5p;hsa-miR-92a-3p;hsa-miR-940 18 GNG7 Sponge network -7.871 0 -4.495 0 0.468
94

RP11-887P2.5

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-196a-5p;hsa-miR-20a-5p;hsa-miR-2110;hsa-miR-219a-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-454-3p;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-590-5p;hsa-miR-7-1-3p;hsa-miR-93-5p 21 PDGFRA Sponge network -9.865 1.0E-5 -4.316 1.0E-5 0.464
95

RP11-344E13.3

 hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-2110;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-454-3p;hsa-miR-589-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 22 PDGFRA Sponge network -4.307 3.0E-5 -4.316 1.0E-5 0.461
96

CTD-2554C21.3

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-7-1-3p 11 PDGFRA Sponge network -6.258 0.00703 -4.316 1.0E-5 0.459
97

RP11-166D19.1

 hsa-miR-141-5p;hsa-miR-200a-5p;hsa-miR-200b-3p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-3607-3p;hsa-miR-429;hsa-miR-452-5p;hsa-miR-590-3p;hsa-miR-944 10 ITGA1 Sponge network -4.209 2.0E-5 -1.265 0.08839 0.458
98

ZNF667-AS1

 hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-452-5p;hsa-miR-484 12 FGF7 Sponge network -4.019 0.00137 -5.509 0 0.458
99

RP11-344E13.3

 hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-532-3p;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-93-5p 12 COL1A1 Sponge network -4.307 3.0E-5 -1.841 0.04283 0.458
100

USP3-AS1

 hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-452-5p;hsa-miR-486-5p 11 FGF7 Sponge network -4.151 0 -5.509 0 0.456
101

MAGI2-AS3

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-590-3p;hsa-miR-671-5p 10 KIT Sponge network -4.563 0 -2.927 0.01211 0.45
102 RP11-760H22.2 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-20a-3p;hsa-miR-22-5p;hsa-miR-320b;hsa-miR-9-3p;hsa-miR-944 10 PRLR Sponge network -3.418 0.00912 -5.28 0.00088 0.447
103

HAND2-AS1

 hsa-miR-130a-5p;hsa-miR-149-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-429;hsa-miR-590-3p 10 KDR Sponge network -7.871 0 -3.788 0 0.447
104 CTC-559E9.5 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-576-5p 10 PDGFRA Sponge network -2.253 0.00403 -4.316 1.0E-5 0.447
105

TRHDE-AS1

 hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p 12 FGF7 Sponge network -6.205 0.01165 -5.509 0 0.439
106

ACTA2-AS1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-2110;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-454-3p;hsa-miR-550a-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-944;hsa-miR-96-5p 26 PDGFRA Sponge network -6.142 0.00223 -4.316 1.0E-5 0.439
107 HOXA11-AS hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-2110;hsa-miR-224-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-454-3p 16 PDGFRA Sponge network -3.349 0.00194 -4.316 1.0E-5 0.438
108

RP11-166D19.1

 hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-1976;hsa-miR-200a-3p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-3615;hsa-miR-616-5p;hsa-miR-9-5p;hsa-miR-92a-3p;hsa-miR-96-5p 15 GNG7 Sponge network -4.209 2.0E-5 -4.495 0 0.435
109

WT1-AS

 hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-31-5p;hsa-miR-330-5p;hsa-miR-3615;hsa-miR-9-5p;hsa-miR-92a-3p;hsa-miR-940;hsa-miR-96-5p 17 GNG7 Sponge network -6.875 2.0E-5 -4.495 0 0.435
110

HAND2-AS1

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-7-5p;hsa-miR-92a-3p;hsa-miR-92b-3p 14 COL1A2 Sponge network -7.871 0 -2.407 0.0132 0.435
111

CTD-2554C21.3

 hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-27a-3p;hsa-miR-484;hsa-miR-7-1-3p 10 FGF7 Sponge network -6.258 0.00703 -5.509 0 0.435
112

MIR497HG

 hsa-miR-130a-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-200a-3p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-31-5p;hsa-miR-3127-5p;hsa-miR-330-5p;hsa-miR-3615;hsa-miR-940 17 GNG7 Sponge network -6.146 0.00024 -4.495 0 0.434
113 CTC-296K1.3 hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-2110;hsa-miR-301a-3p;hsa-miR-330-5p;hsa-miR-454-3p;hsa-miR-616-5p 17 PDGFRA Sponge network -6.944 0.00011 -4.316 1.0E-5 0.43
114

PGM5-AS1

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-484;hsa-miR-7-1-3p 10 FGF7 Sponge network -14.107 0 -5.509 0 0.427
115

ADAMTS9-AS1

 hsa-miR-130a-5p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-19b-1-5p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p 10 KDR Sponge network -8.573 0.00012 -3.788 0 0.425
116

TRHDE-AS1

 hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-200a-3p;hsa-miR-2110;hsa-miR-224-5p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-550a-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p 20 PDGFRA Sponge network -6.205 0.01165 -4.316 1.0E-5 0.425
117

RP11-130L8.1

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-590-3p;hsa-miR-590-5p 10 FGF7 Sponge network -4.329 1.0E-5 -5.509 0 0.424
118

ZNF582-AS1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-224-5p;hsa-miR-33a-5p;hsa-miR-576-5p;hsa-miR-93-5p;hsa-miR-944 14 PDGFRA Sponge network -4.925 0.00112 -4.316 1.0E-5 0.424
119

MIR497HG

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-196a-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-2110;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 20 PDGFRA Sponge network -6.146 0.00024 -4.316 1.0E-5 0.424
120

NR2F2-AS1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-944 16 PDGFRA Sponge network -3.785 0.00281 -4.316 1.0E-5 0.422
121

EMX2OS

 hsa-miR-1271-5p;hsa-miR-17-3p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-31-5p;hsa-miR-330-5p;hsa-miR-92a-3p;hsa-miR-940 14 GNG7 Sponge network -6.205 0.00015 -4.495 0 0.42
122

MAGI2-AS3

 hsa-let-7d-5p;hsa-miR-16-2-3p;hsa-miR-18a-3p;hsa-miR-1976;hsa-miR-24-3p;hsa-miR-25-3p;hsa-miR-33a-3p;hsa-miR-9-3p;hsa-miR-92a-1-5p;hsa-miR-92a-3p 10 CREB3L2 Sponge network -4.563 0 -2.05 0.00075 0.417
123

PGM5-AS1

 hsa-miR-130a-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-200a-3p;hsa-miR-22-5p;hsa-miR-23a-3p 11 GNG7 Sponge network -14.107 0 -4.495 0 0.417
124

PGM5-AS1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-193a-3p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-7-1-3p 15 PDGFRA Sponge network -14.107 0 -4.316 1.0E-5 0.412
125

ADAMTS9-AS1

 hsa-miR-130a-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-200a-3p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-31-3p;hsa-miR-31-5p;hsa-miR-330-5p;hsa-miR-92a-3p;hsa-miR-940;hsa-miR-96-5p 18 GNG7 Sponge network -8.573 0.00012 -4.495 0 0.412
126

RP11-597D13.9

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-219a-5p;hsa-miR-301a-3p;hsa-miR-421;hsa-miR-429;hsa-miR-454-3p;hsa-miR-93-5p;hsa-miR-96-5p 16 PDGFRA Sponge network -2.494 0.07597 -4.316 1.0E-5 0.41
127

RP11-284N8.3

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200a-3p;hsa-miR-219a-5p;hsa-miR-24-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 13 PDGFRA Sponge network -0.845 0.52848 -4.316 1.0E-5 0.409
128

EMX2OS

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7f-5p;hsa-miR-193a-3p;hsa-miR-19b-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-330-5p;hsa-miR-590-3p;hsa-miR-7-5p;hsa-miR-92a-3p 11 COL1A2 Sponge network -6.205 0.00015 -2.407 0.0132 0.408
129 RP11-116O18.1 hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-219a-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-590-3p;hsa-miR-590-5p 14 PDGFRA Sponge network -5.007 0.06008 -4.316 1.0E-5 0.406
130

HAND2-AS1

 hsa-let-7d-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-23a-5p;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-93-5p 10 COL1A1 Sponge network -7.871 0 -1.841 0.04283 0.405
131

HAND2-AS1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-93-5p 11 THBS2 Sponge network -7.871 0 -2.628 0.00636 0.398
132

NR2F1-AS1

 hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-452-5p;hsa-miR-484;hsa-miR-590-3p 12 FGF7 Sponge network -2.961 0.00154 -5.509 0 0.395
133 AC005682.5 hsa-miR-106a-5p;hsa-miR-10a-3p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-3065-3p;hsa-miR-3065-5p 11 CCND2 Sponge network -2.193 0.07184 -2.811 0.0014 0.394
134

RP11-150O12.3

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p 13 PDGFRA Sponge network -4.03 0.14448 -4.316 1.0E-5 0.393
135

RP11-887P2.5

 hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-330-5p;hsa-miR-3615;hsa-miR-940 11 GNG7 Sponge network -9.865 1.0E-5 -4.495 0 0.393
136

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-27a-3p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-590-3p 12 INSR Sponge network -6.205 0.00015 -1.824 0.00037 0.392
137

FAM66C

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-22-5p;hsa-miR-3614-5p 10 PRLR Sponge network -2.927 0.00012 -5.28 0.00088 0.392
138

MAGI2-AS3

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-3614-5p;hsa-miR-9-3p 13 PRLR Sponge network -4.563 0 -5.28 0.00088 0.391
139

TPTEP1

 hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-1976;hsa-miR-224-5p;hsa-miR-31-3p;hsa-miR-31-5p;hsa-miR-330-5p;hsa-miR-92a-3p 11 GNG7 Sponge network -4.398 5.0E-5 -4.495 0 0.39
140

RASSF8-AS1

 hsa-let-7a-3p;hsa-miR-106b-5p;hsa-miR-16-1-3p;hsa-miR-193a-3p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-590-3p;hsa-miR-944 11 PDGFRA Sponge network -2.562 0.00163 -4.316 1.0E-5 0.388
141

RP11-54O7.3

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-16-1-3p;hsa-miR-193a-3p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-33a-5p;hsa-miR-33b-5p 10 PDGFRA Sponge network -2.864 0.01902 -4.316 1.0E-5 0.386
142

ADAMTS9-AS1

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-32-5p;hsa-miR-330-5p;hsa-miR-363-3p;hsa-miR-590-3p;hsa-miR-7-5p;hsa-miR-92a-3p;hsa-miR-92b-3p 13 COL1A2 Sponge network -8.573 0.00012 -2.407 0.0132 0.385
143

ZNF667-AS1

 hsa-let-7f-1-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-452-5p;hsa-miR-629-5p 10 IGF1 Sponge network -4.019 0.00137 -4.485 0.00149 0.383
144

DIO3OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-219a-5p;hsa-miR-33a-5p;hsa-miR-33b-5p 13 PDGFRA Sponge network -4.295 0.00689 -4.316 1.0E-5 0.383
145 RP11-244O19.1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-93-5p 12 CCND2 Sponge network -1.318 0.0924 -2.811 0.0014 0.383
146

FAM66C

 hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-940 10 IGF1 Sponge network -2.927 0.00012 -4.485 0.00149 0.38
147

ADAMTS9-AS1

 hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-421;hsa-miR-590-3p;hsa-miR-671-5p 10 KIT Sponge network -8.573 0.00012 -2.927 0.01211 0.379
148

ADAMTS9-AS1

 hsa-let-7d-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-23a-5p;hsa-miR-590-3p;hsa-miR-625-5p;hsa-miR-92a-1-5p;hsa-miR-93-5p 11 COL1A1 Sponge network -8.573 0.00012 -1.841 0.04283 0.378
149

LINC00284

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-590-3p;hsa-miR-944 13 PDGFRA Sponge network -5.478 0.02716 -4.316 1.0E-5 0.375
150

DIO3OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-378a-3p 13 CCND2 Sponge network -4.295 0.00689 -2.811 0.0014 0.374
151

ACTA2-AS1

 hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-19b-3p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-20a-5p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p 10 THBS1 Sponge network -6.142 0.00223 -3.751 0.0001 0.37
152

ZNF667-AS1

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-339-5p 11 PDGFRA Sponge network -4.019 0.00137 -4.316 1.0E-5 0.369
153

EMX2OS

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-421;hsa-miR-590-3p;hsa-miR-671-5p 11 KIT Sponge network -6.205 0.00015 -2.927 0.01211 0.363
154

WT1-AS

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-330-5p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-92a-3p 12 COL1A2 Sponge network -6.875 2.0E-5 -2.407 0.0132 0.36
155 CTB-92J24.3 hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-33a-5p;hsa-miR-93-5p;hsa-miR-944 12 PDGFRA Sponge network -7.226 0.0046 -4.316 1.0E-5 0.36
156

RP11-130L8.1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-27a-3p;hsa-miR-590-3p;hsa-miR-590-5p 11 INSR Sponge network -4.329 1.0E-5 -1.824 0.00037 0.36
157

RP11-774O3.3

 hsa-let-7f-1-3p;hsa-miR-107;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-7-1-3p 10 FGF7 Sponge network -1.989 0.00136 -5.509 0 0.358
158

RP11-161M6.2

 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-550a-5p;hsa-miR-93-5p 12 PDGFRA Sponge network -2.608 0.00296 -4.316 1.0E-5 0.357
159

ADAMTS9-AS1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-335-3p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-93-5p;hsa-miR-96-5p 12 THBS2 Sponge network -8.573 0.00012 -2.628 0.00636 0.355
160

DNM3OS

 hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-182-5p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-1976;hsa-miR-200a-3p;hsa-miR-224-5p;hsa-miR-31-3p;hsa-miR-616-5p;hsa-miR-940;hsa-miR-96-5p 13 GNG7 Sponge network -3.933 0.00059 -4.495 0 0.355
161

RP11-54O7.3

 hsa-let-7a-3p;hsa-let-7b-3p;hsa-let-7b-5p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-27a-3p;hsa-miR-330-5p 11 INSR Sponge network -2.864 0.01902 -1.824 0.00037 0.351
162

ACTA2-AS1

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-let-7g-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-25-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-7-5p 10 COL1A2 Sponge network -6.142 0.00223 -2.407 0.0132 0.351
163

WT1-AS

 hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-32-3p;hsa-miR-335-3p;hsa-miR-590-3p;hsa-miR-93-5p;hsa-miR-96-5p 11 THBS2 Sponge network -6.875 2.0E-5 -2.628 0.00636 0.351
164

HAND2-AS1

 hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-21-5p;hsa-miR-24-2-5p;hsa-miR-33b-5p;hsa-miR-365a-3p;hsa-miR-429;hsa-miR-629-5p;hsa-miR-7-5p 12 BCL2 Sponge network -7.871 0 -3.063 1.0E-5 0.35
165

HAND2-AS1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-27a-3p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-590-3p 11 INSR Sponge network -7.871 0 -1.824 0.00037 0.348
166

LINC00284

 hsa-miR-142-3p;hsa-miR-142-5p;hsa-miR-155-5p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-221-5p;hsa-miR-330-5p;hsa-miR-590-3p;hsa-miR-944 10 FGF9 Sponge network -5.478 0.02716 -4.087 0.01073 0.346
167

ADAMTS9-AS1

 hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-21-5p;hsa-miR-24-2-5p;hsa-miR-365a-3p;hsa-miR-429;hsa-miR-629-5p;hsa-miR-7-5p 11 BCL2 Sponge network -8.573 0.00012 -3.063 1.0E-5 0.346
168

FAM66C

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-let-7g-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 18 PDGFRA Sponge network -2.927 0.00012 -4.316 1.0E-5 0.346
169

EMX2OS

 hsa-let-7d-5p;hsa-let-7f-5p;hsa-miR-106b-5p;hsa-miR-107;hsa-miR-17-5p;hsa-miR-20a-5p;hsa-miR-23a-5p;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-93-5p 10 COL1A1 Sponge network -6.205 0.00015 -1.841 0.04283 0.346
170

FAM66C

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-5p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-590-3p;hsa-miR-590-5p 10 INSR Sponge network -2.927 0.00012 -1.824 0.00037 0.341
171

RP11-166D19.1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-96-5p 18 CCND2 Sponge network -4.209 2.0E-5 -2.811 0.0014 0.339
172

RP11-344E13.3

 hsa-miR-1271-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-185-3p;hsa-miR-18a-5p;hsa-miR-1976;hsa-miR-200a-3p;hsa-miR-31-3p;hsa-miR-31-5p;hsa-miR-330-5p;hsa-miR-3615 11 GNG7 Sponge network -4.307 3.0E-5 -4.495 0 0.339
173 RP11-890B15.3 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-20b-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-330-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-576-5p;hsa-miR-93-5p 13 PDGFRA Sponge network -2.059 0.00641 -4.316 1.0E-5 0.337
174 RP11-439M11.1 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-20b-5p;hsa-miR-324-3p 10 CCND2 Sponge network -2.662 0.21003 -2.811 0.0014 0.337
175 LINC00861 hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-219a-5p;hsa-miR-24-3p;hsa-miR-301a-3p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-429;hsa-miR-589-3p;hsa-miR-590-5p;hsa-miR-96-5p 14 PDGFRA Sponge network 0.999 0.45301 -4.316 1.0E-5 0.334
176

RP11-166D19.1

 hsa-let-7d-5p;hsa-miR-16-2-3p;hsa-miR-18a-3p;hsa-miR-1976;hsa-miR-24-3p;hsa-miR-25-3p;hsa-miR-33a-3p;hsa-miR-9-5p;hsa-miR-92a-3p;hsa-miR-944 10 CREB3L2 Sponge network -4.209 2.0E-5 -2.05 0.00075 0.333
177

ACTA2-AS1

 hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-576-5p 12 IGF1 Sponge network -6.142 0.00223 -4.485 0.00149 0.332
178

WT1-AS

 hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-590-3p 10 INSR Sponge network -6.875 2.0E-5 -1.824 0.00037 0.332
179

NR2F2-AS1

 hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-31-5p;hsa-miR-452-5p;hsa-miR-590-3p 11 FGF7 Sponge network -3.785 0.00281 -5.509 0 0.329
180

MAGI2-AS3

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-590-3p 11 INSR Sponge network -4.563 0 -1.824 0.00037 0.327
181

RASSF8-AS1

 hsa-let-7a-3p;hsa-let-7b-3p;hsa-miR-142-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-27a-3p;hsa-miR-342-3p;hsa-miR-590-3p 10 INSR Sponge network -2.562 0.00163 -1.824 0.00037 0.327
182

LINC00865

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200a-3p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-219a-5p;hsa-miR-301a-3p;hsa-miR-339-5p;hsa-miR-429;hsa-miR-616-5p 15 PDGFRA Sponge network -1.585 0.19508 -4.316 1.0E-5 0.321
183

RP11-13K12.1

 hsa-miR-130a-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-31-5p 10 GNG7 Sponge network -5.093 0.01151 -4.495 0 0.319
184

MAGI2-AS3

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-9-3p;hsa-miR-93-5p 19 CCND2 Sponge network -4.563 0 -2.811 0.0014 0.315
185

ACTA2-AS1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-3614-5p;hsa-miR-590-3p;hsa-miR-96-5p 10 THBS2 Sponge network -6.142 0.00223 -2.628 0.00636 0.313
186

RP11-284N8.3

 hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-3065-5p;hsa-miR-324-3p;hsa-miR-93-5p;hsa-miR-96-5p 10 CCND2 Sponge network -0.845 0.52848 -2.811 0.0014 0.313
187

TRHDE-AS1

 hsa-miR-130a-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-1976;hsa-miR-200a-3p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-31-3p;hsa-miR-31-5p;hsa-miR-330-5p;hsa-miR-92a-3p 15 GNG7 Sponge network -6.205 0.01165 -4.495 0 0.312
188 RP11-567M16.1 hsa-let-7g-3p;hsa-miR-141-3p;hsa-miR-17-5p;hsa-miR-200a-3p;hsa-miR-2110;hsa-miR-219a-5p;hsa-miR-330-5p;hsa-miR-339-5p;hsa-miR-590-5p;hsa-miR-616-5p;hsa-miR-93-5p 11 PDGFRA Sponge network -2.638 0.21408 -4.316 1.0E-5 0.309
189

RP11-166D19.1

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-33a-3p;hsa-miR-3614-5p;hsa-miR-9-5p;hsa-miR-944 10 PRLR Sponge network -4.209 2.0E-5 -5.28 0.00088 0.309
190

NR2F2-AS1

 hsa-miR-1271-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-31-5p;hsa-miR-3615;hsa-miR-92a-3p 11 GNG7 Sponge network -3.785 0.00281 -4.495 0 0.308
191 KTN1-AS1 hsa-let-7c-5p;hsa-miR-125b-5p;hsa-miR-192-5p;hsa-miR-194-3p;hsa-miR-194-5p;hsa-miR-215-5p;hsa-miR-29b-2-5p;hsa-miR-378c;hsa-miR-592;hsa-miR-99a-5p 10 IGF1R Sponge network 0.218 0.748 -0.352 0.58959 0.306
192

ADAMTS9-AS1

 hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-590-3p;hsa-miR-590-5p 10 INSR Sponge network -8.573 0.00012 -1.824 0.00037 0.305
193

MIR143HG

 hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-21-5p;hsa-miR-215-5p;hsa-miR-24-2-5p;hsa-miR-3065-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-629-5p;hsa-miR-7-5p 13 BCL2 Sponge network -6.51 0 -3.063 1.0E-5 0.304
194

TPTEP1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-15a-5p;hsa-miR-15b-3p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-590-3p 10 INSR Sponge network -4.398 5.0E-5 -1.824 0.00037 0.302
195 GAS6-AS2 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-3065-5p;hsa-miR-324-3p;hsa-miR-429 14 CCND2 Sponge network -1.941 0.0681 -2.811 0.0014 0.301
196

FAM66C

 hsa-miR-17-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-330-5p;hsa-miR-92a-3p;hsa-miR-940 10 GNG7 Sponge network -2.927 0.00012 -4.495 0 0.301
197

TRHDE-AS1

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-22-5p;hsa-miR-32-3p;hsa-miR-330-3p;hsa-miR-3614-5p;hsa-miR-582-5p 10 PRLR Sponge network -6.205 0.01165 -5.28 0.00088 0.297
198

RP11-389C8.2

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-224-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-33a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p 17 CCND2 Sponge network -3.089 2.0E-5 -2.811 0.0014 0.293
199 BZRAP1-AS1 hsa-let-7a-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-219a-5p;hsa-miR-224-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-93-5p 12 PDGFRA Sponge network -1.931 0.08861 -4.316 1.0E-5 0.292
200

ACTA2-AS1

 hsa-let-7a-3p;hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130a-3p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-22-5p;hsa-miR-33a-3p;hsa-miR-3614-5p;hsa-miR-944 13 PRLR Sponge network -6.142 0.00223 -5.28 0.00088 0.291
201

RP11-554A11.4

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-33a-3p 10 CCND2 Sponge network -5.361 2.0E-5 -2.811 0.0014 0.29
202

FAM66C

 hsa-let-7f-1-3p;hsa-miR-15a-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-18a-3p;hsa-miR-20a-5p;hsa-miR-27a-3p;hsa-miR-429;hsa-miR-484;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-7-1-3p 13 FGF7 Sponge network -2.927 0.00012 -5.509 0 0.29
203

SOCS2-AS1

 hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-141-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-616-5p;hsa-miR-93-5p 14 PDGFRA Sponge network -4.167 1.0E-5 -4.316 1.0E-5 0.288
204

LINC00865

 hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-1-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-20a-5p;hsa-miR-30d-3p;hsa-miR-429;hsa-miR-501-5p;hsa-miR-616-5p 10 FGF7 Sponge network -1.585 0.19508 -5.509 0 0.287
205

WT1-AS

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-22-5p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-421;hsa-miR-9-3p;hsa-miR-9-5p;hsa-miR-944 13 PRLR Sponge network -6.875 2.0E-5 -5.28 0.00088 0.286
206

MIR143HG

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-224-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p 21 CCND2 Sponge network -6.51 0 -2.811 0.0014 0.285
207

TRHDE-AS1

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-193a-3p;hsa-miR-25-3p;hsa-miR-32-3p;hsa-miR-32-5p;hsa-miR-330-5p;hsa-miR-590-3p;hsa-miR-92a-3p;hsa-miR-92b-3p 10 COL1A2 Sponge network -6.205 0.01165 -2.407 0.0132 0.282
208

DNM3OS

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-33a-3p 10 PRLR Sponge network -3.933 0.00059 -5.28 0.00088 0.279
209

MAGI2-AS3

 hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-200a-5p;hsa-miR-200b-5p;hsa-miR-200c-3p;hsa-miR-21-5p;hsa-miR-24-2-5p;hsa-miR-3065-5p;hsa-miR-33b-5p;hsa-miR-429;hsa-miR-629-5p;hsa-miR-7-5p 12 BCL2 Sponge network -4.563 0 -3.063 1.0E-5 0.277
210

LINC00284

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-15b-3p;hsa-miR-16-5p;hsa-miR-205-5p;hsa-miR-27a-3p;hsa-miR-27b-3p;hsa-miR-330-5p;hsa-miR-590-3p 10 INSR Sponge network -5.478 0.02716 -1.824 0.00037 0.276
211

HAND2-AS1

 hsa-let-7d-5p;hsa-miR-16-2-3p;hsa-miR-18a-3p;hsa-miR-1976;hsa-miR-24-3p;hsa-miR-25-3p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-92a-3p;hsa-miR-944 10 CREB3L2 Sponge network -7.871 0 -2.05 0.00075 0.274
212

RP11-774O3.3

 hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-2110;hsa-miR-219a-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-330-5p;hsa-miR-335-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-421;hsa-miR-7-1-3p 16 PDGFRA Sponge network -1.989 0.00136 -4.316 1.0E-5 0.269
213

ACTA2-AS1

 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-193a-3p;hsa-miR-193b-3p;hsa-miR-205-5p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-590-3p;hsa-miR-671-5p 10 KIT Sponge network -6.142 0.00223 -2.927 0.01211 0.267
214

MIR143HG

 hsa-let-7d-5p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-142-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-330-3p;hsa-miR-33a-3p;hsa-miR-3614-5p 10 PRLR Sponge network -6.51 0 -5.28 0.00088 0.267
215 RP11-819C21.1 hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-106b-5p;hsa-miR-16-1-3p;hsa-miR-219a-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-550a-5p;hsa-miR-590-3p;hsa-miR-93-5p 12 PDGFRA Sponge network -1.571 0.00379 -4.316 1.0E-5 0.264
216

CTD-2554C21.2

 hsa-miR-130a-5p;hsa-miR-141-3p;hsa-miR-17-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-23a-3p 10 GNG7 Sponge network -6.968 0.00817 -4.495 0 0.26
217 PCED1B-AS1 hsa-miR-130b-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-219a-5p;hsa-miR-24-3p;hsa-miR-335-3p;hsa-miR-429;hsa-miR-93-5p;hsa-miR-96-5p 10 PDGFRA Sponge network 0.764 0.37397 -4.316 1.0E-5 0.26
218

SOCS2-AS1

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-324-3p;hsa-miR-33a-3p;hsa-miR-93-5p 12 CCND2 Sponge network -4.167 1.0E-5 -2.811 0.0014 0.258
219

RP11-597D13.9

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-200a-3p;hsa-miR-20b-5p;hsa-miR-30d-3p;hsa-miR-429;hsa-miR-93-5p;hsa-miR-96-5p 14 CCND2 Sponge network -2.494 0.07597 -2.811 0.0014 0.252
220

LINC00672

 hsa-let-7a-3p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-24-3p;hsa-miR-27a-3p;hsa-miR-339-5p;hsa-miR-33a-5p;hsa-miR-33b-5p;hsa-miR-550a-5p;hsa-miR-590-3p;hsa-miR-93-5p 15 PDGFRA Sponge network -2.547 4.0E-5 -4.316 1.0E-5 0.252
221

RP11-597D13.9

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-16-2-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-20a-5p;hsa-miR-20b-5p;hsa-miR-32-3p;hsa-miR-93-5p;hsa-miR-96-5p 10 THBS2 Sponge network -2.494 0.07597 -2.628 0.00636 0.252
222

RP11-150O12.3

 hsa-miR-1271-5p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-23a-3p;hsa-miR-330-5p;hsa-miR-3615;hsa-miR-92a-3p 10 GNG7 Sponge network -4.03 0.14448 -4.495 0 0.251
223 LINC00839 hsa-let-7g-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-196a-5p;hsa-miR-20b-5p;hsa-miR-301a-3p;hsa-miR-330-5p;hsa-miR-550a-5p;hsa-miR-93-5p 13 PDGFRA Sponge network -2.505 0.08591 -4.316 1.0E-5 0.251
224

RP11-774O3.3

 hsa-miR-17-3p;hsa-miR-185-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-31-5p;hsa-miR-330-5p 10 GNG7 Sponge network -1.989 0.00136 -4.495 0 0.25
225

DNM3OS

 hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-130b-5p;hsa-miR-141-3p;hsa-miR-15b-5p;hsa-miR-16-2-3p;hsa-miR-182-5p;hsa-miR-183-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-3065-3p;hsa-miR-3065-5p;hsa-miR-30d-3p;hsa-miR-33a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-550a-5p;hsa-miR-93-5p;hsa-miR-96-5p 19 CCND2 Sponge network -3.933 0.00059 -2.811 0.0014 0.25
226

NR2F1-AS1

 hsa-miR-130a-5p;hsa-miR-141-3p;hsa-miR-18a-3p;hsa-miR-18a-5p;hsa-miR-193b-5p;hsa-miR-1976;hsa-miR-22-5p;hsa-miR-224-5p;hsa-miR-31-5p;hsa-miR-330-5p;hsa-miR-3615 11 GNG7 Sponge network -2.961 0.00154 -4.495 0 0.25

Quest ID: 88ca48bb66eb535c668812a9c33796e6